Survey of Performance and Management at the Food and Drug Administration (FDA)

U.S. Government Accountability Office

Contents

(Return to main page)

Introduction

The U.S. Government Accountability Office (GAO), the evaluation arm of Congress, is studying the use of performance information at FDA as part of a Congressional request. As part of this study, we are surveying a random sample of mid- and upper-level federal employees at FDA. This survey is designed to obtain information on your experiences and perceptions with regard to performance management and related challenges.

This survey is based on similar surveys that we administered in 1996, 1999, 2003, and 2007. Most of the questions in this survey can be answered by checking boxes or filling in blanks. The survey should take no more than 20-25 minutes to complete.

We urge you to complete this survey. We cannot develop meaningful information without your frank and honest answers.

To learn more about completing the survey, printing your responses, and who to contact if you have questions, _____.

Thank you in advance for your assistance in taking part in our survey.

(View question)

Background Information

1. What is your current grade level?

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers GS/GM-13 or equivalent 15.1 11.8-18.3
  GS/GM-14 or equivalent 31.7 26.8-36.7
  GS/GM-15 or equivalent 36.8 31.9-41.8
  Senior Executive Service or equivalent 10.6 8.1-13.5
  Other - Please specify below, then continue 5.4 3.3-8.5
  Not checked/No Answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers GS/GM-13 or equivalent 2.0 0.3-6.3
  GS/GM-14 or equivalent 33.1 25.0-41.3
  GS/GM-15 or equivalent 48.8 40.1-57.5
  Senior Executive Service or equivalent 11.1 6.9-16.6
  Other - Please specify below, then continue 5.0 1.9-10.5
  Not checked/No Answer 0.0 0.0-2.9
3--CFSAN Managers GS/GM-13 or equivalent 1.7 0.2-6.1
  GS/GM-14 or equivalent 40.1 31.1-49.1
  GS/GM-15 or equivalent 40.1 31.1-49.1
  Senior Executive Service or equivalent 13.2 8.1-19.9
  Other - Please specify below, then continue 5.0 1.8-10.9
  Not checked/No Answer 0.0 0.0-4.8
4--ORA Managers GS/GM-13 or equivalent 41.2 32.4-50.1
  GS/GM-14 or equivalent 32.6 24.1-41.0
  GS/GM-15 or equivalent 14.1 8.4-21.7
  Senior Executive Service or equivalent 3.4 1.3-7.2
  Other - Please specify below, then continue 7.6 3.5-14.0
  Not checked/No Answer 1.1 0.1-5.0

If you answered "Other" above, please specify your grade level.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


2. In total, for how many years have you been a supervisor and/or
a manager at FDA?
(Please specify the total number of years, rounding up to the nearest year.)

(View question)

Total number of years as a supervisor and/or
a manager at FDA. (Enter number.)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Estimate 95 Percent
Confidence Interval
1--All FDA Managers Estimated Mean 8.9 8.1-9.7
  Estimated Median 6.5 5.6-7.7
2--CDER/CBER/CDRH M Estimated Mean 9.1 7.8-10.3
  Estimated Median 6.9 5.4-8.4
3--CFSAN Managers Estimated Mean 8.2 6.9-9.5
  Estimated Median 6.2 4.1-7.4
4--ORA Managers Estimated Mean 9.0 7.6-10.3
  Estimated Median 6.1 5.1-8.4

If you have never been a supervisor or a
manager at FDA, click on the box below.

(View question)

1.

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


3. In your current role, approximately how many FDA employees and contractors are you
responsible for?
(Please answer for your permanent position. Please specify the total number. If none, enter 0.)

(View question)

Number of FDA employees . . .

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Number of contractors . . . . . . .

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


4. Where do you work? (If you are currently on temporary assignment or on detail,
please answer for your permanent work location.)


(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Inside the Washington, DC metropolitan area 66.9 63.9-69.8
  Outside the Washington, DC metropolitan area 32.3 29.3-35.3
  Not checked/No Answer 0.8 0.2-2.2
2--CDER/CBER/CDRH Managers Inside the Washington, DC metropolitan area 94.8 89.1-98.0
  Outside the Washington, DC metropolitan area 5.2 2.0-10.9
  Not checked/No Answer 0.0 0.0-2.9
3--CFSAN Managers Inside the Washington, DC metropolitan area 93.3 87.0-97.2
  Outside the Washington, DC metropolitan area 6.7 2.8-13.0
  Not checked/No Answer 0.0 0.0-4.8
4--ORA Managers Inside the Washington, DC metropolitan area 13.6 8.1-21.0
  Outside the Washington, DC metropolitan area 84.2 76.5-90.2
  Not checked/No Answer 2.2 0.4-6.7

5. For which FDA Center or Office do you work?

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Center for Biologics Evaluation and Research 9.6 9.3-10.0
  Center for Device and Radiological Health (C 10.9 10.7-11.0
  Center for Drug Evaluation and Research (CDE 17.7 17.0-18.4
  Center for Food Safety and Applied Nutrition 9.8 9.6-10.0
  Center for Veterinary Medicine (CVM) 5.3 5.2-5.3
  Office of Regulatory Affairs (ORA) 30.8 29.5-32.2
  Office of the Commissioner - National Center 1.8 1.6-2.0
  Office of the Commissioner - Other 12.1 10.9-13.2
  Other - Please specify below, then continue. 2.1 0.8-4.4
  Not checked/No Answer 0.0 0.0-1.0

If you answered "Other" above, please specify your FDA Center or Office.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


FDA's Strategic Goals

For the following questions, please interpret "performance measures" in the broadest sense.

(View question)

6. For those program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all,
do you consider FDA's strategic goals when participating in the following activities?

(View question)

6a. Setting program priorities

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 36.0 30.8-41.2
  Great extent 37.7 32.6-42.9
  Moderate extent 14.8 11.5-18.8
  Small extent 4.4 2.5-7.2
  No extent 2.6 1.1-5.2
  No basis to judge/Not applicable 4.1 2.1-7.0
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 30.6 22.3-38.9
  Great extent 43.8 35.0-52.7
  Moderate extent 18.2 11.9-26.2
  Small extent 3.2 0.8-8.3
  No extent 2.1 0.3-6.8
  No basis to judge/Not applicable 2.0 0.3-6.3
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 27.1 19.1-35.2
  Great extent 41.7 32.7-50.8
  Moderate extent 24.4 16.9-33.4
  Small extent 5.0 1.8-10.9
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 42.9 34.1-51.8
  Great extent 28.8 20.7-37.0
  Moderate extent 10.9 5.9-17.9
  Small extent 6.5 2.8-12.6
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 6.5 2.8-12.6
  No answer 1.1 0.1-5.0

6b. Allocating resources

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 29.2 24.3-34.1
  Great extent 38.7 33.5-43.9
  Moderate extent 18.7 14.7-22.8
  Small extent 4.0 2.1-6.9
  No extent 3.4 1.6-6.1
  No basis to judge/Not applicable 5.6 3.3-8.9
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 23.3 16.0-31.9
  Great extent 47.2 38.3-56.1
  Moderate extent 18.5 12.0-26.6
  Small extent 2.9 0.8-7.4
  No extent 3.1 0.8-8.2
  No basis to judge/Not applicable 5.0 2.0-10.3
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 21.1 14.0-29.7
  Great extent 41.1 32.1-50.2
  Moderate extent 26.1 18.3-35.2
  Small extent 6.7 2.8-13.0
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 35.3 26.8-43.9
  Great extent 31.0 22.7-39.3
  Moderate extent 20.6 13.7-29.0
  Small extent 3.3 0.9-8.3
  No extent 4.3 1.5-9.8
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 1.1 0.1-5.0

6c. Adopting new program approaches or changing work processes

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 29.0 24.1-33.8
  Great extent 39.4 34.2-44.6
  Moderate extent 21.8 17.5-26.2
  Small extent 3.7 2.1-6.0
  No extent 2.3 0.9-4.7
  No basis to judge/Not applicable 3.4 1.6-6.3
  No answer 0.5 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 26.0 18.5-34.8
  Great extent 43.5 34.9-52.2
  Moderate extent 23.2 15.9-31.8
  Small extent 3.1 1.0-7.2
  No extent 1.2 0.1-5.7
  No basis to judge/Not applicable 3.0 0.8-7.7
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 16.1 9.9-24.1
  Great extent 36.7 27.9-45.6
  Moderate extent 33.8 25.2-42.5
  Small extent 11.7 6.4-19.1
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 35.3 26.8-43.9
  Great extent 34.3 25.8-42.8
  Moderate extent 20.6 13.7-29.0
  Small extent 2.2 0.4-6.7
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 1.1 0.1-5.0

6d. Developing or refining program performance measures

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 24.1 19.5-28.7
  Great extent 37.4 32.2-42.6
  Moderate extent 22.4 17.9-26.9
  Small extent 7.0 4.6-10.1
  No extent 2.2 0.8-4.7
  No basis to judge/Not applicable 6.6 4.1-10.0
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 21.1 14.2-29.5
  Great extent 37.2 28.6-45.8
  Moderate extent 24.2 16.8-32.8
  Small extent 7.2 3.3-13.3
  No extent 2.4 0.4-7.4
  No basis to judge/Not applicable 7.9 3.9-13.9
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 13.4 7.7-21.1
  Great extent 47.2 38.0-56.4
  Moderate extent 24.4 16.9-33.4
  Small extent 11.7 6.4-19.1
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 24.5 17.1-33.2
  Great extent 37.2 28.5-45.9
  Moderate extent 22.0 15.0-30.5
  Small extent 7.6 3.5-14.0
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 6.5 2.8-12.6
  No answer 1.1 0.1-5.0

7. For those program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all, do you consider goals from the following FDA plans or initiatives when making management decisions such as setting priorities or allocating resources?

(View question)

7a. Food Protection Plan

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 19.0 15.6-22.4
  Great extent 13.1 10.0-16.7
  Moderate extent 7.0 5.1-9.5
  Small extent 7.4 4.7-10.9
  No extent 11.4 8.1-15.4
  No basis to judge/Not applicable 39.8 35.0-44.6
  No answer 2.4 1.1-4.7
2--CDER/CBER/CDRH Managers Very great extent 1.0 0.1-4.8
  Great extent 0.0 0.0-2.9
  Moderate extent 0.0 0.0-2.9
  Small extent 3.2 0.8-8.3
  No extent 22.3 15.1-30.9
  No basis to judge/Not applicable 67.7 59.3-76.0
  No answer 5.9 2.4-11.7
3--CFSAN Managers Very great extent 42.2 33.1-51.2
  Great extent 22.8 15.4-31.6
  Moderate extent 21.7 14.5-30.5
  Small extent 1.7 0.2-6.1
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 31.0 22.7-39.3
  Great extent 23.1 15.9-31.7
  Moderate extent 11.2 6.2-18.2
  Small extent 13.0 7.5-20.5
  No extent 4.3 1.5-9.8
  No basis to judge/Not applicable 17.4 11.0-25.4
  No answer 0.0 0.0-3.1

7b. Critical Path Initiative

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.3 6.3-13.0
  Great extent 22.0 17.6-26.5
  Moderate extent 20.3 16.0-24.6
  Small extent 16.6 12.7-21.0
  No extent 9.2 6.5-12.5
  No basis to judge/Not applicable 21.9 17.5-26.3
  No answer 0.8 0.1-3.0
2--CDER/CBER/CDRH Managers Very great extent 10.2 5.4-17.1
  Great extent 30.4 22.2-38.6
  Moderate extent 19.2 12.6-27.5
  Small extent 20.0 13.3-28.2
  No extent 5.1 1.9-10.7
  No basis to judge/Not applicable 15.1 9.3-22.8
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 11.7 6.4-19.1
  Moderate extent 12.1 7.0-19.1
  Small extent 25.0 17.4-34.1
  No extent 16.7 10.3-24.9
  No basis to judge/Not applicable 29.4 21.1-37.8
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 3.6 1.1-8.4
  Great extent 19.8 13.1-28.1
  Moderate extent 23.9 16.5-32.6
  Small extent 9.8 5.1-16.6
  No extent 15.5 9.5-23.3
  No basis to judge/Not applicable 27.4 19.4-35.5
  No answer 0.0 0.0-3.1

7c. ORA Revitalization Plan

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 4.9 3.1-7.5
  Great extent 9.6 6.9-13.1
  Moderate extent 13.8 10.6-17.5
  Small extent 10.8 7.6-14.7
  No extent 14.0 10.6-18.1
  No basis to judge/Not applicable 44.4 39.6-49.3
  No answer 2.4 1.1-4.7
2--CDER/CBER/CDRH Managers Very great extent 0.0 0.0-2.9
  Great extent 0.3 0.1-0.9
  Moderate extent 4.8 1.7-10.3
  Small extent 7.5 3.4-14.0
  No extent 16.5 10.4-24.3
  No basis to judge/Not applicable 65.1 56.7-73.5
  No answer 5.9 2.4-11.7
3--CFSAN Managers Very great extent 0.0 0.0-4.8
  Great extent 5.0 1.8-10.9
  Moderate extent 21.1 14.0-29.7
  Small extent 8.3 4.0-15.1
  No extent 30.1 21.6-38.5
  No basis to judge/Not applicable 33.8 25.2-42.5
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 15.5 9.5-23.3
  Great extent 20.2 13.4-28.4
  Moderate extent 25.3 17.8-34.1
  Small extent 13.0 7.5-20.5
  No extent 9.8 5.1-16.6
  No basis to judge/Not applicable 16.3 10.1-24.2
  No answer 0.0 0.0-3.1

7d. Other - Please specify below.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


If you answered "Other" above, please specify other FDA plans or initiatives you consider when making management decisions.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Performance Measurement

8. Are there performance measures for the program(s)/operation(s)/project(s) that you are involved with?

(View question)

(Note: For respondents not answering "Yes" to this question, the responses for questions 9, 10, 12,
and 13 are set to "No Answer".)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Yes - (Continue with question 9.) 73.1 68.3-77.9
  No 19.0 14.7-23.4
  Do not know 6.5 4.0-9.9
  Not checked 1.4 0.5-3.2
2--CDER/CBER/CDRH Managers Yes - (Continue with question 9.) 70.0 61.8-78.2
  No 21.1 14.2-29.4
  Do not know 7.1 3.2-13.2
  Not checked 1.9 0.3-5.8
3--CFSAN Managers Yes - (Continue with question 9.) 80.6 72.2-87.4
  No 15.0 9.0-23.0
  Do not know 4.4 1.6-9.4
  Not checked 0.0 0.0-4.8
4--ORA Managers Yes - (Continue with question 9.) 80.2 71.9-86.9
  No 13.3 7.8-20.7
  Do not know 4.3 1.5-9.8
  Not checked 2.2 0.4-6.7

9. To what extent, if at all, do you agree with the following statements as they relate to
performance measures for the program(s)/operation(s)/project(s) that you are involved with?

(View question)

9a. We have performance measures that tell us how many things we produce or services we provide. (Output measures)

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 26.4 21.7-31.1
  Great extent 26.9 22.2-31.7
  Moderate extent 12.5 9.3-16.4
  Small extent 4.2 2.4-6.7
  No extent 1.7 0.7-3.5
  No basis to judge/Not applicable 1.3 0.3-3.6
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 23.5 16.3-32.1
  Great extent 25.4 17.9-34.0
  Moderate extent 14.8 9.0-22.4
  Small extent 5.4 2.0-11.3
  No extent 0.9 0.1-4.4
  No basis to judge/Not applicable 0.0 0.0-2.9
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 28.4 20.1-36.7
  Great extent 24.4 16.9-33.4
  Moderate extent 19.4 12.6-27.9
  Small extent 5.0 1.8-10.9
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 31.3 23.0-39.6
  Great extent 30.4 22.1-38.7
  Moderate extent 8.7 4.3-15.3
  Small extent 4.3 1.5-9.8
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 19.8 13.1-28.1

9b. We have performance measures that tell us if we are operating efficiently. (Efficiency measures)

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.5 6.6-13.0
  Great extent 25.3 20.7-29.8
  Moderate extent 22.1 17.8-26.5
  Small extent 10.4 7.5-14.0
  No extent 4.9 3.0-7.6
  No basis to judge/Not applicable 0.5 0.1-1.7
  No answer 27.3 22.5-32.1
2--CDER/CBER/CDRH Managers Very great extent 6.0 2.5-11.7
  Great extent 17.8 11.8-25.3
  Moderate extent 26.6 18.7-34.5
  Small extent 13.5 7.9-21.1
  No extent 6.1 2.5-12.0
  No basis to judge/Not applicable 0.0 0.0-2.9
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 13.4 7.7-21.1
  Great extent 21.7 14.5-30.5
  Moderate extent 17.7 11.3-26.0
  Small extent 17.7 11.3-26.0
  No extent 8.3 4.0-15.1
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 8.7 4.3-15.3
  Great extent 34.3 25.8-42.8
  Moderate extent 21.7 14.7-30.2
  Small extent 7.9 3.8-14.2
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 20.9 14.0-29.3

9c. We have performance measures that tell us whether or not we are satisfying our customers. (Customer service measures)

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 7.1 4.5-10.4
  Great extent 20.5 16.1-24.8
  Moderate extent 25.4 20.8-30.0
  Small extent 13.1 9.8-17.0
  No extent 5.0 3.2-7.5
  No basis to judge/Not applicable 2.0 0.8-4.0
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 6.4 2.7-12.4
  Great extent 15.9 10.0-23.5
  Moderate extent 27.3 19.3-35.3
  Small extent 12.3 7.1-19.4
  No extent 6.1 2.6-12.1
  No basis to judge/Not applicable 2.0 0.3-6.3
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 8.3 4.0-15.1
  Great extent 18.4 11.7-26.8
  Moderate extent 20.5 13.6-28.8
  Small extent 16.7 10.3-24.9
  No extent 15.0 9.0-23.0
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 6.5 2.8-12.6
  Great extent 23.1 15.9-31.7
  Moderate extent 26.4 18.7-35.2
  Small extent 17.7 11.3-25.7
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 19.8 13.1-28.1

9d. We have performance measures that tell us about the quality of the products or services we provide. (Quality measures)

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.3 6.4-12.9
  Great extent 27.3 22.5-32.0
  Moderate extent 22.3 17.9-26.6
  Small extent 9.5 6.8-12.9
  No extent 4.6 2.7-7.2
  No basis to judge/Not applicable 0.2 0.0-0.6
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 9.4 4.7-16.2
  Great extent 22.3 15.4-30.6
  Moderate extent 19.3 12.9-27.3
  Small extent 12.8 7.4-20.2
  No extent 6.1 2.6-12.1
  No basis to judge/Not applicable 0.0 0.0-2.9
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 8.3 4.0-15.1
  Great extent 29.4 21.1-37.8
  Moderate extent 19.4 12.6-27.9
  Small extent 13.4 7.7-21.1
  No extent 8.3 4.0-15.1
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 10.9 5.9-17.9
  Great extent 29.3 21.1-37.5
  Moderate extent 25.9 18.4-34.6
  Small extent 9.8 5.1-16.6
  No extent 4.3 1.5-9.8
  No basis to judge/Not applicable 0.0 0.0-3.1
  No answer 19.8 13.1-28.1

9e. We have performance measures that would demonstrate to someone outside of our agency whether or not we are achieving our intended results. (Outcome measures)

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 12.5 9.1-16.6
  Great extent 31.2 26.3-36.1
  Moderate extent 15.5 11.9-19.7
  Small extent 9.1 6.5-12.3
  No extent 3.5 1.9-5.9
  No basis to judge/Not applicable 1.3 0.3-3.7
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 12.3 7.0-19.5
  Great extent 27.8 19.8-35.8
  Moderate extent 17.7 11.5-25.4
  Small extent 7.0 3.2-13.2
  No extent 4.2 1.4-9.6
  No basis to judge/Not applicable 1.0 0.1-4.8
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 16.7 10.3-24.9
  Great extent 30.1 21.6-38.5
  Moderate extent 12.1 7.0-19.1
  Small extent 16.7 10.3-24.9
  No extent 5.0 1.8-10.9
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 7.6 3.5-14.0
  Great extent 38.0 29.3-46.7
  Moderate extent 15.5 9.5-23.3
  Small extent 13.6 8.1-21.0
  No extent 4.3 1.5-9.8
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 19.8 13.1-28.1

9f. We have performance measures that link our product or service costs with the results we achieve. (Cost-benefit measures)

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 4.6 2.5-7.5
  Great extent 9.6 6.7-13.3
  Moderate extent 16.1 12.4-20.4
  Small extent 17.2 13.4-21.1
  No extent 12.8 9.6-16.5
  No basis to judge/Not applicable 12.8 9.3-16.9
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 3.1 0.8-8.2
  Great extent 3.4 1.1-8.0
  Moderate extent 15.6 9.8-23.2
  Small extent 15.7 9.8-23.5
  No extent 16.7 10.5-24.6
  No basis to judge/Not applicable 15.4 9.4-23.2
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 6.7 2.8-13.0
  Moderate extent 14.4 8.6-22.1
  Small extent 27.8 19.5-36.0
  No extent 18.4 11.7-26.8
  No basis to judge/Not applicable 10.0 5.1-17.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 2.2 0.4-6.7
  Great extent 16.3 10.1-24.2
  Moderate extent 16.6 10.4-24.5
  Small extent 18.8 12.2-26.9
  No extent 13.3 7.8-20.7
  No basis to judge/Not applicable 13.0 7.5-20.5
  No answer 19.8 13.1-28.1

Performance Measurement (Continued)

10. For those program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all, do you use the information obtained from performance measurement when participating in the following activities?

(View question)

10a. Developing program strategy

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 10.8 7.6-14.7
  Great extent 29.4 24.6-34.2
  Moderate extent 22.8 18.4-27.2
  Small extent 5.1 3.1-7.9
  No extent 1.8 0.7-3.7
  No basis to judge/Not applicable 3.1 1.4-5.9
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 6.8 3.2-12.7
  Great extent 27.8 19.8-35.7
  Moderate extent 26.2 18.6-35.1
  Small extent 6.9 3.2-12.9
  No extent 1.2 0.1-5.7
  No basis to judge/Not applicable 1.0 0.1-4.8
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 36.1 27.3-45.0
  Moderate extent 29.4 21.1-37.8
  Small extent 3.3 0.9-8.6
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 13.0 7.5-20.5
  Great extent 33.5 25.1-41.9
  Moderate extent 19.5 12.8-27.8
  Small extent 6.5 2.8-12.6
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 19.8 13.1-28.1

10b. Setting program priorities

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 15.3 11.6-19.6
  Great extent 33.2 28.3-38.2
  Moderate extent 13.8 10.4-17.8
  Small extent 5.8 3.5-9.0
  No extent 2.1 0.9-4.3
  No basis to judge/Not applicable 2.5 1.1-5.0
  No answer 27.3 22.5-32.1
2--CDER/CBER/CDRH Managers Very great extent 11.9 6.8-19.0
  Great extent 32.8 24.4-41.1
  Moderate extent 14.7 8.9-22.4
  Small extent 7.2 3.2-13.5
  No extent 2.4 0.4-7.4
  No basis to judge/Not applicable 1.0 0.1-4.8
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 41.1 32.1-50.2
  Moderate extent 26.1 18.3-35.2
  Small extent 3.3 0.9-8.6
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 19.5 12.8-27.8
  Great extent 35.7 27.1-44.2
  Moderate extent 9.8 5.1-16.6
  Small extent 6.5 2.8-12.6
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 20.9 14.0-29.3

10c. Allocating resources

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 14.0 10.6-18.1
  Great extent 33.1 28.1-38.1
  Moderate extent 16.8 12.8-20.7
  Small extent 3.4 1.8-5.8
  No extent 1.8 0.7-3.5
  No basis to judge/Not applicable 3.6 1.8-6.4
  No answer 27.3 22.5-32.1
2--CDER/CBER/CDRH Managers Very great extent 12.5 7.3-19.5
  Great extent 29.5 21.5-37.5
  Moderate extent 19.7 13.0-27.9
  Small extent 3.1 0.8-8.2
  No extent 1.0 0.1-4.8
  No basis to judge/Not applicable 3.2 0.8-8.3
  No answer 31.0 22.7-39.3
3--CFSAN Managers Very great extent 9.4 4.8-16.1
  Great extent 36.7 27.9-45.6
  Moderate extent 22.8 15.4-31.6
  Small extent 5.0 1.8-10.9
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 16.3 10.1-24.2
  Great extent 38.9 30.2-47.6
  Moderate extent 13.0 7.5-20.5
  Small extent 5.4 2.1-11.2
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 19.8 13.1-28.1

10d. Identifying program problems to be addressed

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 14.3 10.7-18.7
  Great extent 32.3 27.4-37.2
  Moderate extent 19.2 14.9-23.4
  Small extent 3.4 1.9-5.7
  No extent 1.5 0.5-3.3
  No basis to judge/Not applicable 1.4 0.4-3.3
  No answer 27.9 23.1-32.8
2--CDER/CBER/CDRH Managers Very great extent 11.1 6.1-18.1
  Great extent 35.2 26.7-43.7
  Moderate extent 17.4 11.1-25.4
  Small extent 2.9 0.8-7.6
  No extent 1.2 0.1-5.7
  No basis to judge/Not applicable 2.2 0.3-7.0
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 11.7 6.4-19.1
  Great extent 36.1 27.3-45.0
  Moderate extent 21.7 14.5-30.5
  Small extent 4.4 1.6-9.4
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 21.1 14.0-29.7
4--ORA Managers Very great extent 14.1 8.4-21.7
  Great extent 36.1 27.5-44.8
  Moderate extent 20.2 13.4-28.4
  Small extent 5.4 2.1-11.2
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 20.9 14.0-29.3

10e. Taking corrective action to solve program problems

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 14.1 10.4-18.4
  Great extent 33.6 28.7-38.6
  Moderate extent 16.6 12.8-20.5
  Small extent 5.8 3.5-8.8
  No extent 1.2 0.4-3.1
  No basis to judge/Not applicable 1.4 0.4-3.3
  No answer 27.3 22.5-32.1
2--CDER/CBER/CDRH Managers Very great extent 12.1 6.9-19.2
  Great extent 33.5 25.2-41.9
  Moderate extent 16.7 10.5-24.5
  Small extent 3.1 0.8-8.2
  No extent 2.4 0.4-7.4
  No basis to judge/Not applicable 2.2 0.3-7.0
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 10.0 5.1-17.1
  Great extent 29.4 21.1-37.8
  Moderate extent 31.1 22.6-39.6
  Small extent 5.0 1.8-10.9
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 14.1 8.4-21.7
  Great extent 38.3 29.6-47.0
  Moderate extent 14.7 9.0-22.3
  Small extent 10.9 5.9-17.9
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 20.9 14.0-29.3

10f. Adopting new program approaches or changing work processes

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.7 6.8-13.4
  Great extent 35.5 30.5-40.6
  Moderate extent 19.6 15.3-23.8
  Small extent 5.7 3.6-8.7
  No extent 1.5 0.5-3.3
  No basis to judge/Not applicable 1.0 0.2-2.8
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 4.3 1.6-9.0
  Great extent 39.1 30.4-47.8
  Moderate extent 17.1 10.8-25.0
  Small extent 6.1 2.6-12.1
  No extent 1.2 0.1-5.7
  No basis to judge/Not applicable 2.2 0.3-7.0
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 8.3 4.0-15.1
  Great extent 41.1 32.1-50.2
  Moderate extent 23.4 15.9-32.3
  Small extent 2.7 0.8-6.7
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 11.9 6.7-19.2
  Great extent 36.1 27.5-44.8
  Moderate extent 20.2 13.4-28.4
  Small extent 9.8 5.1-16.6
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 0.0 0.0-3.1
  No answer 19.8 13.1-28.1

10g. Coordinating program efforts with other internal or external organizations

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.3 6.4-13.1
  Great extent 29.2 24.4-33.9
  Moderate extent 20.2 16.0-24.5
  Small extent 9.9 7.1-13.5
  No extent 1.8 0.6-4.1
  No basis to judge/Not applicable 2.6 1.3-4.8
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 6.3 2.8-12.1
  Great extent 27.5 19.6-35.4
  Moderate extent 23.7 16.5-32.3
  Small extent 9.4 4.7-16.2
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 3.1 0.8-8.2
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 25.0 17.4-34.1
  Moderate extent 24.4 16.9-33.4
  Small extent 17.7 11.3-26.0
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 10.9 5.9-17.9
  Great extent 37.5 28.8-46.2
  Moderate extent 16.6 10.4-24.5
  Small extent 10.9 5.9-17.9
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 19.8 13.1-28.1

10h. Refining program performance measures

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.1 6.3-12.7
  Great extent 24.9 20.3-29.6
  Moderate extent 23.5 19.0-27.9
  Small extent 7.5 5.0-10.7
  No extent 3.5 1.9-5.7
  No basis to judge/Not applicable 4.6 2.6-7.4
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 7.7 3.7-13.7
  Great extent 26.2 18.6-35.1
  Moderate extent 23.5 16.6-31.7
  Small extent 8.6 4.2-15.4
  No extent 0.9 0.1-4.4
  No basis to judge/Not applicable 2.9 0.8-7.6
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 30.1 21.6-38.5
  Moderate extent 32.2 23.6-40.7
  Small extent 5.0 1.8-10.9
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 7.6 3.5-14.0
  Great extent 25.3 17.8-34.1
  Moderate extent 19.5 12.8-27.8
  Small extent 11.2 6.2-18.2
  No extent 8.7 4.3-15.3
  No basis to judge/Not applicable 7.9 3.8-14.2
  No answer 19.8 13.1-28.1

10i. Setting new or revising existing performance goals

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 10.9 7.8-14.8
  Great extent 26.6 22.0-31.3
  Moderate extent 22.8 18.4-27.3
  Small extent 4.8 2.8-7.6
  No extent 2.7 1.4-4.8
  No basis to judge/Not applicable 5.1 2.9-8.2
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 8.1 4.0-14.4
  Great extent 27.1 19.1-35.0
  Moderate extent 26.3 18.8-35.0
  Small extent 5.5 2.1-11.5
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 2.9 0.8-7.6
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 10.0 5.1-17.1
  Great extent 34.4 25.7-43.2
  Moderate extent 27.8 19.5-36.0
  Small extent 1.7 0.2-6.1
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 9.8 5.1-16.6
  Great extent 28.5 20.4-36.6
  Moderate extent 19.1 12.5-27.2
  Small extent 7.6 3.5-14.0
  No extent 7.6 3.5-14.0
  No basis to judge/Not applicable 7.6 3.5-14.0
  No answer 19.8 13.1-28.1

10j. Setting individual job expectations for the government employees I manage or supervise

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 15.7 12.1-19.9
  Great extent 39.7 34.5-44.8
  Moderate extent 10.8 7.7-14.5
  Small extent 3.9 2.2-6.5
  No extent 0.8 0.2-2.3
  No basis to judge/Not applicable 2.0 0.8-4.2
  No answer 27.1 22.3-31.9
2--CDER/CBER/CDRH Managers Very great extent 12.7 7.3-20.0
  Great extent 43.3 34.7-52.0
  Moderate extent 8.3 4.2-14.3
  Small extent 2.5 0.5-7.1
  No extent 1.2 0.1-5.7
  No basis to judge/Not applicable 2.0 0.3-6.3
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 16.1 9.9-24.1
  Great extent 36.7 27.9-45.6
  Moderate extent 10.0 5.1-17.1
  Small extent 7.7 3.7-14.0
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 21.1 14.0-29.7
4--ORA Managers Very great extent 20.6 13.7-29.0
  Great extent 41.6 32.7-50.4
  Moderate extent 13.0 7.5-20.5
  Small extent 4.6 1.7-10.0
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 0.3 0.1-0.7
  No answer 19.8 13.1-28.1

10k. Rewarding government employees I manage or supervise

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 16.1 12.4-20.3
  Great extent 37.4 32.4-42.5
  Moderate extent 11.3 8.2-15.1
  Small extent 3.1 1.6-5.5
  No extent 1.9 0.7-4.3
  No basis to judge/Not applicable 3.2 1.5-5.8
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 14.8 9.0-22.4
  Great extent 37.0 28.6-45.4
  Moderate extent 11.6 6.5-18.7
  Small extent 1.5 0.2-5.5
  No extent 2.2 0.3-7.0
  No basis to judge/Not applicable 2.9 0.8-7.6
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 12.7 7.3-20.2
  Great extent 30.1 21.6-38.5
  Moderate extent 17.7 11.3-26.0
  Small extent 6.7 2.8-13.0
  No extent 5.0 1.8-10.9
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 22.8 15.6-31.4
  Great extent 44.0 35.1-52.9
  Moderate extent 10.1 5.4-16.9
  Small extent 3.3 0.9-8.3
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 0.0 0.0-3.1
  No answer 19.8 13.1-28.1

10l. Developing and managing contracts

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.6 3.5-8.5
  Great extent 13.0 9.8-16.8
  Moderate extent 12.4 9.2-16.2
  Small extent 6.3 3.9-9.5
  No extent 7.0 4.5-10.4
  No basis to judge/Not applicable 28.8 24.0-33.6
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 3.1 0.8-8.0
  Great extent 14.3 8.7-21.8
  Moderate extent 12.9 7.6-20.1
  Small extent 6.7 2.8-13.0
  No extent 6.3 2.6-12.5
  No basis to judge/Not applicable 26.6 19.0-34.3
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 8.3 4.0-15.1
  Great extent 10.0 5.1-17.1
  Moderate extent 22.8 15.4-31.6
  Small extent 6.1 2.6-11.8
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 31.7 23.2-40.3
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 6.5 2.8-12.6
  Great extent 14.1 8.4-21.7
  Moderate extent 7.6 3.5-14.0
  Small extent 7.9 3.8-14.2
  No extent 11.9 6.7-19.2
  No basis to judge/Not applicable 32.1 23.7-40.5
  No answer 19.8 13.1-28.1

10m. Identifying and sharing effective program approaches with others

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 7.1 4.5-10.6
  Great extent 25.8 21.2-30.4
  Moderate extent 20.3 16.2-24.4
  Small extent 11.0 8.0-14.7
  No extent 2.7 1.2-5.2
  No basis to judge/Not applicable 5.7 3.4-9.0
  No answer 27.3 22.5-32.1
2--CDER/CBER/CDRH Managers Very great extent 6.5 2.7-12.8
  Great extent 24.5 17.4-32.8
  Moderate extent 18.2 11.8-26.2
  Small extent 11.8 6.5-19.2
  No extent 2.9 0.8-7.4
  No basis to judge/Not applicable 6.1 2.5-12.0
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 21.7 14.5-30.5
  Moderate extent 32.8 24.1-41.4
  Small extent 12.7 7.3-20.2
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 7.6 3.5-14.0
  Great extent 27.4 19.4-35.5
  Moderate extent 23.9 16.5-32.6
  Small extent 14.4 8.7-22.0
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 3.6 1.1-8.4
  No answer 20.9 14.0-29.3

11. Please provide an example of how you use performance information.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


12. Over the past several years, for those program(s)/operation(s)/project(s) that you are involved with, has managers' use of performance information at FDA increased, decreased or remained about the same?

Managers' use of performance information at FDA has ...

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Increased greatly 16.4 12.5-21.0
  Increased somewhat 27.3 22.7-31.9
  Stayed about the same 21.4 17.0-25.8
  Decreased somewhat 0.9 0.2-2.3
  Decreased greatly 0.2 0.0-0.6
  No basis to judge 6.7 4.4-9.8
  No answer 27.1 22.3-31.9
2--CDER/CBER/CDRH Managers Increased greatly 13.1 7.6-20.6
  Increased somewhat 25.9 18.5-34.5
  Stayed about the same 23.2 15.9-31.9
  Decreased somewhat 0.0 0.0-2.9
  Decreased greatly 0.0 0.0-2.9
  No basis to judge 7.7 3.8-13.5
  No answer 30.0 21.8-38.2
3--CFSAN Managers Increased greatly 3.3 0.9-8.6
  Increased somewhat 35.5 26.8-44.2
  Stayed about the same 28.4 20.1-36.7
  Decreased somewhat 1.7 0.2-6.1
  Decreased greatly 1.7 0.2-6.1
  No basis to judge 8.3 4.0-15.1
  No answer 21.1 14.0-29.7
4--ORA Managers Increased greatly 22.0 15.0-30.5
  Increased somewhat 28.8 20.7-37.0
  Stayed about the same 20.6 13.7-29.0
  Decreased somewhat 2.2 0.4-6.7
  Decreased greatly 0.0 0.0-3.1
  No basis to judge 6.5 2.8-12.6
  No answer 19.8 13.1-28.1

Performance Measurement (Continued)

13. Based on your experience with the program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all, have the following factors hindered measuring performance or using the performance information?

(View question)

13a. Difficulty determining meaningful measures

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.5 8.3-15.3
  Great extent 18.3 14.3-22.2
  Moderate extent 22.2 17.7-26.6
  Small extent 11.9 8.6-15.9
  No extent 6.6 4.1-10.0
  No basis to judge/Not applicable 2.1 1.0-4.1
  No answer 27.5 22.6-32.3
2--CDER/CBER/CDRH Managers Very great extent 10.5 5.7-17.2
  Great extent 20.5 13.8-28.6
  Moderate extent 21.7 14.7-30.2
  Small extent 11.6 6.4-19.0
  No extent 3.6 1.1-8.6
  No basis to judge/Not applicable 2.1 0.3-6.8
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 16.1 9.9-24.1
  Great extent 14.4 8.6-22.1
  Moderate extent 25.0 17.4-34.1
  Small extent 10.0 5.1-17.1
  No extent 8.3 4.0-15.1
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 21.1 14.0-29.7
4--ORA Managers Very great extent 10.7 5.9-17.4
  Great extent 22.8 15.6-31.4
  Moderate extent 21.7 14.7-30.2
  Small extent 15.2 9.3-23.0
  No extent 6.5 2.8-12.6
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 20.9 14.0-29.3

13b. Different parties are using different definitions to measure performance

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 8.9 6.1-12.4
  Great extent 17.9 14.0-21.7
  Moderate extent 23.6 19.0-28.2
  Small extent 12.5 9.3-16.2
  No extent 7.1 4.5-10.5
  No basis to judge/Not applicable 3.0 1.5-5.3
  No answer 27.1 22.3-31.9
2--CDER/CBER/CDRH Managers Very great extent 11.9 6.7-19.2
  Great extent 18.5 11.9-26.7
  Moderate extent 24.9 17.5-33.5
  Small extent 8.6 4.6-14.6
  No extent 4.0 1.3-8.9
  No basis to judge/Not applicable 2.1 0.3-6.8
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 13.4 7.7-21.1
  Great extent 22.1 15.0-30.7
  Moderate extent 16.7 10.3-24.9
  Small extent 13.4 7.7-21.1
  No extent 8.3 4.0-15.1
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 21.1 14.0-29.7
4--ORA Managers Very great extent 5.4 2.1-11.2
  Great extent 20.2 13.4-28.4
  Moderate extent 23.9 16.5-32.6
  Small extent 19.8 13.1-28.1
  No extent 7.6 3.5-14.0
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 19.8 13.1-28.1

13c. Difficulty obtaining valid or reliable data

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 7.0 4.5-10.2
  Great extent 12.0 8.9-15.9
  Moderate extent 23.3 18.8-27.8
  Small extent 20.5 16.2-24.9
  No extent 7.3 4.9-10.4
  No basis to judge/Not applicable 2.9 1.4-5.2
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 6.0 2.5-11.7
  Great extent 12.1 6.9-19.2
  Moderate extent 25.2 18.0-33.6
  Small extent 19.8 13.0-28.0
  No extent 4.8 1.7-10.3
  No basis to judge/Not applicable 2.1 0.3-6.8
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 11.7 6.4-19.1
  Great extent 15.5 9.6-23.1
  Moderate extent 18.4 11.7-26.8
  Small extent 21.7 14.5-30.5
  No extent 10.0 5.1-17.1
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 5.7 2.4-11.4
  Great extent 12.2 7.0-19.5
  Moderate extent 26.0 18.4-34.9
  Small extent 21.7 14.7-30.2
  No extent 10.9 5.9-17.9
  No basis to judge/Not applicable 3.6 1.1-8.4
  No answer 19.8 13.1-28.1

13d. Difficulty obtaining data in time to be useful

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.2 3.1-8.0
  Great extent 10.9 8.1-14.2
  Moderate extent 21.0 16.7-25.4
  Small extent 20.7 16.4-25.0
  No extent 11.2 8.0-15.1
  No basis to judge/Not applicable 1.6 0.7-3.2
  No answer 29.4 24.6-34.3
2--CDER/CBER/CDRH Managers Very great extent 6.3 2.8-12.0
  Great extent 13.2 7.8-20.5
  Moderate extent 16.8 10.8-24.3
  Small extent 22.7 15.5-31.3
  No extent 6.9 3.1-13.1
  No basis to judge/Not applicable 0.9 0.1-4.4
  No answer 33.2 24.7-41.6
3--CFSAN Managers Very great extent 8.3 4.0-15.1
  Great extent 15.5 9.6-23.1
  Moderate extent 23.4 15.9-32.3
  Small extent 13.4 7.7-21.1
  No extent 16.7 10.3-24.9
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 3.3 0.9-8.3
  Great extent 9.3 4.8-15.8
  Moderate extent 25.0 17.5-33.8
  Small extent 25.0 17.5-33.8
  No extent 13.0 7.5-20.5
  No basis to judge/Not applicable 2.5 0.6-6.8
  No answer 22.0 15.0-30.5

13e. Lack of incentives (e.g., rewards, positive recognition)

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.6 8.4-15.5
  Great extent 12.7 9.3-16.7
  Moderate extent 20.9 16.7-25.1
  Small extent 15.4 11.8-19.7
  No extent 8.7 6.0-12.2
  No basis to judge/Not applicable 2.5 1.2-4.6
  No answer 28.1 23.3-33.0
2--CDER/CBER/CDRH Managers Very great extent 14.7 8.9-22.4
  Great extent 10.1 5.4-16.8
  Moderate extent 17.6 11.7-25.0
  Small extent 17.9 11.7-25.8
  No extent 5.4 2.2-11.1
  No basis to judge/Not applicable 1.2 0.1-5.7
  No answer 33.1 24.6-41.6
3--CFSAN Managers Very great extent 18.4 11.7-26.8
  Great extent 14.4 8.6-22.1
  Moderate extent 16.7 10.3-24.9
  Small extent 15.0 9.0-23.0
  No extent 9.4 4.8-16.1
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 5.7 2.4-11.4
  Great extent 13.3 7.8-20.7
  Moderate extent 30.4 22.1-38.7
  Small extent 16.3 10.1-24.2
  No extent 11.9 6.7-19.2
  No basis to judge/Not applicable 2.5 0.6-6.8
  No answer 19.8 13.1-28.1

13f. Difficulty resolving conflicting interests of stakeholders, either internal or external

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.5 3.4-8.5
  Great extent 9.3 6.5-12.9
  Moderate extent 15.9 12.3-19.5
  Small extent 21.1 16.8-25.4
  No extent 13.5 9.9-17.9
  No basis to judge/Not applicable 7.7 5.2-10.9
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 2.2 0.3-7.0
  Great extent 11.3 6.3-18.3
  Moderate extent 13.8 8.2-21.2
  Small extent 21.3 14.5-29.5
  No extent 12.5 7.2-19.8
  No basis to judge/Not applicable 8.9 4.6-15.2
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 11.7 6.4-19.1
  Great extent 10.0 5.1-17.1
  Moderate extent 20.5 13.6-28.8
  Small extent 20.0 13.1-28.6
  No extent 10.0 5.1-17.1
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 5.7 2.4-11.4
  Great extent 9.8 5.1-16.6
  Moderate extent 20.9 14.0-29.3
  Small extent 22.8 15.6-31.4
  No extent 11.9 6.7-19.2
  No basis to judge/Not applicable 9.0 4.6-15.6
  No answer 19.8 13.1-28.1

13g. Difficulty distinguishing between the results produced by the program and results caused by other factors

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.5 3.5-8.2
  Great extent 7.0 4.7-10.0
  Moderate extent 22.8 18.5-27.2
  Small extent 18.4 14.4-22.4
  No extent 13.6 10.0-17.9
  No basis to judge/Not applicable 5.7 3.5-8.7
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 5.3 2.1-10.6
  Great extent 5.9 2.4-11.7
  Moderate extent 26.6 18.8-34.4
  Small extent 18.3 12.0-26.2
  No extent 7.8 3.7-14.2
  No basis to judge/Not applicable 6.1 2.5-12.0
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 11.7 6.4-19.1
  Great extent 15.5 9.6-23.1
  Moderate extent 18.4 11.7-26.8
  Small extent 11.7 6.4-19.1
  No extent 15.0 9.0-23.0
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 5.7 2.4-11.4
  Great extent 6.5 2.8-12.6
  Moderate extent 25.6 18.1-34.4
  Small extent 22.8 15.6-31.4
  No extent 15.2 9.3-23.0
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 19.8 13.1-28.1

13h. Existing information technology and/or systems not capable of providing needed data

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.4 8.2-15.4
  Great extent 12.0 8.7-16.0
  Moderate extent 19.8 15.6-23.9
  Small extent 16.1 12.4-20.3
  No extent 8.7 5.9-12.2
  No basis to judge/Not applicable 4.4 2.6-6.9
  No answer 27.7 22.9-32.5
2--CDER/CBER/CDRH Managers Very great extent 10.0 5.4-16.6
  Great extent 13.1 7.7-20.3
  Moderate extent 21.7 14.8-30.0
  Small extent 14.2 8.4-21.8
  No extent 5.9 2.5-11.6
  No basis to judge/Not applicable 4.1 1.3-9.5
  No answer 31.0 22.8-39.3
3--CFSAN Managers Very great extent 11.1 6.0-18.2
  Great extent 6.1 2.6-11.8
  Moderate extent 18.4 11.7-26.8
  Small extent 25.0 17.4-34.1
  No extent 11.7 6.4-19.1
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 12.6 7.3-19.7
  Great extent 10.9 5.9-17.9
  Moderate extent 22.8 15.6-31.4
  Small extent 17.4 11.0-25.4
  No extent 9.8 5.1-16.6
  No basis to judge/Not applicable 5.7 2.4-11.4
  No answer 20.9 14.0-29.3

13i. Lack of staff who are knowledgeable about gathering and/or analyzing performance information

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 7.0 4.4-10.5
  Great extent 9.8 7.1-13.2
  Moderate extent 18.2 14.3-22.1
  Small extent 18.8 14.6-22.9
  No extent 13.4 9.8-17.7
  No basis to judge/Not applicable 5.1 3.1-7.8
  No answer 27.7 22.9-32.6
2--CDER/CBER/CDRH Managers Very great extent 5.4 2.0-11.3
  Great extent 10.5 5.8-17.2
  Moderate extent 14.1 8.5-21.5
  Small extent 22.1 15.2-30.3
  No extent 11.6 6.5-18.8
  No basis to judge/Not applicable 5.1 1.9-10.7
  No answer 31.2 22.9-39.5
3--CFSAN Managers Very great extent 9.4 4.8-16.1
  Great extent 11.7 6.4-19.1
  Moderate extent 20.0 13.1-28.6
  Small extent 16.1 9.9-24.1
  No extent 16.7 10.3-24.9
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 6.5 2.8-12.6
  Great extent 11.5 6.4-18.5
  Moderate extent 23.9 16.5-32.6
  Small extent 19.8 13.1-28.1
  No extent 10.9 5.9-17.9
  No basis to judge/Not applicable 6.5 2.8-12.6
  No answer 20.9 14.0-29.3

13j. Lack of ongoing top executive commitment or support for using performance information to make program/funding decisions

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.6 4.1-10.0
  Great extent 8.3 5.8-11.4
  Moderate extent 14.0 10.6-18.0
  Small extent 16.0 12.3-19.6
  No extent 19.5 15.2-23.7
  No basis to judge/Not applicable 8.7 6.1-12.0
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 8.0 3.8-14.5
  Great extent 6.3 2.6-12.5
  Moderate extent 16.8 10.7-24.6
  Small extent 14.3 8.7-21.8
  No extent 15.1 9.5-22.4
  No basis to judge/Not applicable 9.3 4.7-16.1
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 9.4 4.8-16.1
  Great extent 10.0 5.1-17.1
  Moderate extent 13.4 7.7-21.1
  Small extent 19.4 12.6-27.9
  No extent 16.7 10.3-24.9
  No basis to judge/Not applicable 11.7 6.4-19.1
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 4.3 1.5-9.8
  Great extent 14.4 8.7-22.0
  Moderate extent 15.2 9.3-23.0
  Small extent 19.8 13.1-28.1
  No extent 14.4 8.7-22.0
  No basis to judge/Not applicable 11.9 6.7-19.2
  No answer 19.8 13.1-28.1

13k. Lack of ongoing Congressional commitment or support for using performance information to make program/funding decisions

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.1 3.8-9.3
  Great extent 9.6 6.9-12.9
  Moderate extent 10.2 7.3-13.8
  Small extent 10.9 7.7-14.8
  No extent 14.0 10.4-18.3
  No basis to judge/Not applicable 21.8 17.5-26.1
  No answer 27.4 22.6-32.2
2--CDER/CBER/CDRH Managers Very great extent 6.0 2.5-12.0
  Great extent 10.0 5.3-16.7
  Moderate extent 10.3 5.7-16.9
  Small extent 8.9 4.6-15.3
  No extent 12.0 6.9-19.1
  No basis to judge/Not applicable 21.5 14.5-29.9
  No answer 31.2 22.9-39.5
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 10.0 5.1-17.1
  Moderate extent 17.7 11.3-26.0
  Small extent 12.7 7.3-20.2
  No extent 10.0 5.1-17.1
  No basis to judge/Not applicable 23.4 15.9-32.3
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 7.6 3.5-14.0
  Great extent 10.4 5.6-17.1
  Moderate extent 9.8 5.1-16.6
  Small extent 9.8 5.1-16.6
  No extent 14.1 8.4-21.7
  No basis to judge/Not applicable 28.5 20.4-36.6
  No answer 19.8 13.1-28.1

13l. Difficulty determining how to use performance information to improve the program

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 3.6 2.0-6.1
  Great extent 10.2 7.2-13.9
  Moderate extent 18.9 14.9-22.9
  Small extent 24.3 19.8-28.8
  No extent 12.0 8.6-16.0
  No basis to judge/Not applicable 4.1 2.2-6.9
  No answer 26.9 22.2-31.7
2--CDER/CBER/CDRH Managers Very great extent 3.2 0.8-8.3
  Great extent 8.8 4.4-15.3
  Moderate extent 14.2 8.7-21.3
  Small extent 30.8 22.6-39.0
  No extent 8.7 4.3-15.4
  No basis to judge/Not applicable 4.3 1.4-9.9
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 11.7 6.4-19.1
  Moderate extent 19.4 12.6-27.9
  Small extent 24.4 16.9-33.4
  No extent 15.0 9.0-23.0
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 19.4 12.6-27.9
4--ORA Managers Very great extent 6.5 2.8-12.6
  Great extent 11.2 6.2-18.2
  Moderate extent 25.0 17.5-33.8
  Small extent 22.0 15.0-30.5
  No extent 12.2 7.0-19.5
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 19.8 13.1-28.1

13m. Concern that OMB will micromanage programs in my agency

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 4.2 2.4-6.8
  Great extent 6.5 4.2-9.5
  Moderate extent 14.3 10.7-18.6
  Small extent 12.1 8.8-15.9
  No extent 17.0 12.9-21.1
  No basis to judge/Not applicable 18.9 14.9-22.9
  No answer 27.1 22.3-31.9
2--CDER/CBER/CDRH Managers Very great extent 2.2 0.3-7.0
  Great extent 4.2 1.5-9.1
  Moderate extent 13.5 8.0-20.8
  Small extent 13.7 8.1-21.3
  No extent 17.1 10.9-24.9
  No basis to judge/Not applicable 19.3 12.7-27.5
  No answer 30.0 21.8-38.2
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 8.3 4.0-15.1
  Moderate extent 13.8 8.3-21.1
  Small extent 13.4 7.7-21.1
  No extent 13.4 7.7-21.1
  No basis to judge/Not applicable 23.4 15.9-32.3
  No answer 21.1 14.0-29.7
4--ORA Managers Very great extent 4.3 1.5-9.8
  Great extent 7.9 3.8-14.2
  Moderate extent 16.3 10.1-24.2
  Small extent 11.9 6.7-19.2
  No extent 17.7 11.3-25.7
  No basis to judge/Not applicable 22.0 15.0-30.5
  No answer 19.8 13.1-28.1

13n. Other - Please specify below.

(View question)

(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 2.9 1.4-5.2
  Great extent 1.7 0.5-4.1
  Moderate extent 0.7 0.2-1.8
  Small extent 0.0 0.0-1.0
  No extent 1.2 0.3-2.8
  No basis to judge/Not applicable 21.1 16.7-25.5
  No answer 72.5 67.7-77.3
2--CDER/CBER/CDRH Managers Very great extent 2.2 0.3-7.0
  Great extent 1.9 0.3-6.1
  Moderate extent 0.0 0.0-2.9
  Small extent 0.0 0.0-2.9
  No extent 2.1 0.3-6.8
  No basis to judge/Not applicable 18.5 12.0-26.7
  No answer 75.2 66.5-82.7
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 0.0 0.0-4.8
  Moderate extent 3.3 0.9-8.6
  Small extent 0.0 0.0-4.8
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 21.1 14.0-29.7
  No answer 68.9 60.4-77.4
4--ORA Managers Very great extent 5.4 2.1-11.2
  Great extent 1.1 0.1-5.0
  Moderate extent 1.1 0.1-5.0
  Small extent 0.0 0.0-3.1
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 26.0 18.4-34.9
  No answer 66.4 57.9-74.9

If you answered "Other" above, please specify other factors that hindered measuring performance or using the performance information?

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Agency Climate

14. To what extent, if at all, do you agree with the following statements?

(View question)

14a. FDA managers/supervisors at my level have the decision making authority they need to help FDA accomplish its strategic goals.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 8.2 5.5-11.7
  Great extent 33.2 28.2-38.3
  Moderate extent 30.9 25.9-35.9
  Small extent 19.2 15.0-23.4
  No extent 5.7 3.6-8.5
  No basis to judge/Not applicable 1.7 0.7-3.6
  No answer 1.1 0.3-2.8
2--CDER/CBER/CDRH Managers Very great extent 6.7 2.9-12.8
  Great extent 39.9 31.2-48.6
  Moderate extent 31.1 22.8-39.4
  Small extent 13.5 7.9-21.1
  No extent 5.9 2.5-11.5
  No basis to judge/Not applicable 1.9 0.3-6.1
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 27.8 19.5-36.0
  Moderate extent 34.4 25.7-43.2
  Small extent 22.8 15.4-31.6
  No extent 6.7 2.8-13.0
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 8.2 4.1-14.5
  Great extent 27.4 19.4-35.5
  Moderate extent 26.4 18.7-35.2
  Small extent 25.0 17.5-33.8
  No extent 8.7 4.3-15.3
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 2.2 0.4-6.7

14b. FDA managers/supervisors at my level are held accountable for the accomplishment of FDA's strategic goals.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 20.1 15.9-24.4
  Great extent 40.9 35.7-46.1
  Moderate extent 24.5 19.8-29.2
  Small extent 10.0 7.0-13.8
  No extent 1.9 0.6-4.3
  No basis to judge/Not applicable 1.9 0.8-3.6
  No answer 0.7 0.1-2.3
2--CDER/CBER/CDRH Managers Very great extent 14.5 8.8-22.0
  Great extent 46.8 37.9-55.7
  Moderate extent 24.0 16.6-32.6
  Small extent 10.8 5.8-18.0
  No extent 2.0 0.3-6.3
  No basis to judge/Not applicable 0.9 0.1-4.4
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 46.1 37.0-55.3
  Moderate extent 28.8 20.6-37.1
  Small extent 13.4 7.7-21.1
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 29.1 21.0-37.3
  Great extent 38.3 29.6-47.0
  Moderate extent 18.5 11.9-26.6
  Small extent 8.7 4.3-15.3
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 1.1 0.1-5.0

14c. FDA managers/supervisors at my level are held accountable for the results of the program(s)/operation(s)/project(s) they are responsible for.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 30.3 25.4-35.2
  Great extent 46.8 41.5-52.2
  Moderate extent 13.4 10.0-17.6
  Small extent 5.8 3.4-9.0
  No extent 1.4 0.5-3.1
  No basis to judge/Not applicable 1.1 0.4-2.5
  No answer 1.1 0.3-2.8
2--CDER/CBER/CDRH Managers Very great extent 25.7 18.2-34.4
  Great extent 49.9 41.1-58.7
  Moderate extent 15.0 9.1-22.7
  Small extent 6.5 2.7-12.8
  No extent 1.0 0.1-4.8
  No basis to judge/Not applicable 0.9 0.1-4.4
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 13.4 7.7-21.1
  Great extent 52.8 43.6-62.0
  Moderate extent 22.1 15.0-30.7
  Small extent 6.7 2.8-13.0
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 43.6 34.7-52.4
  Great extent 36.9 28.2-45.6
  Moderate extent 9.8 5.1-16.6
  Small extent 4.3 1.5-9.8
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 2.2 0.4-6.7

14d. FDA managers/supervisors at my level use performance information to recognize employees for their performance.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 17.9 14.0-21.9
  Great extent 37.6 32.4-42.8
  Moderate extent 29.6 24.7-34.4
  Small extent 9.5 6.6-13.2
  No extent 2.1 0.7-4.6
  No basis to judge/Not applicable 2.6 1.1-5.1
  No answer 0.7 0.1-2.3
2--CDER/CBER/CDRH Managers Very great extent 12.2 6.9-19.5
  Great extent 39.6 30.9-48.4
  Moderate extent 29.9 21.7-38.1
  Small extent 11.2 6.1-18.3
  No extent 2.9 0.8-7.6
  No basis to judge/Not applicable 3.1 0.8-8.2
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 13.4 7.7-21.1
  Great extent 36.7 27.9-45.6
  Moderate extent 37.2 28.3-46.0
  Small extent 9.4 4.8-16.1
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 28.5 20.4-36.6
  Great extent 36.7 28.1-45.4
  Moderate extent 22.8 15.6-31.4
  Small extent 8.7 4.3-15.3
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 1.1 0.1-5.0

14e. Employees at FDA receive positive recognition for helping FDA accomplish its strategic goals.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 10.2 7.3-13.8
  Great extent 28.6 23.6-33.6
  Moderate extent 32.2 27.2-37.2
  Small extent 23.9 19.3-28.5
  No extent 3.3 1.5-6.3
  No basis to judge/Not applicable 1.0 0.3-2.4
  No answer 0.7 0.1-2.3
2--CDER/CBER/CDRH Managers Very great extent 6.4 2.7-12.6
  Great extent 27.3 19.3-35.2
  Moderate extent 31.0 22.8-39.3
  Small extent 29.1 20.9-37.3
  No extent 4.2 1.4-9.6
  No basis to judge/Not applicable 0.9 0.1-4.4
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 13.4 7.7-21.1
  Great extent 16.7 10.3-24.9
  Moderate extent 35.5 26.8-44.2
  Small extent 31.1 22.6-39.6
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 15.2 9.3-23.0
  Great extent 32.4 24.0-40.8
  Moderate extent 31.8 23.4-40.2
  Small extent 17.4 11.0-25.4
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 1.1 0.1-5.0

14f. FDA is investing the resources needed to ensure that its performance data is of sufficient quality.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 3.4 1.8-5.9
  Great extent 18.6 14.4-22.9
  Moderate extent 31.7 26.7-36.7
  Small extent 23.2 18.7-27.7
  No extent 5.6 3.3-8.8
  No basis to judge/Not applicable 16.6 12.7-20.5
  No answer 0.9 0.2-2.4
2--CDER/CBER/CDRH Managers Very great extent 1.0 0.1-4.8
  Great extent 18.5 12.2-26.4
  Moderate extent 31.0 22.7-39.3
  Small extent 23.1 15.8-31.8
  No extent 6.1 2.6-12.1
  No basis to judge/Not applicable 19.3 12.7-27.5
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 8.3 4.0-15.1
  Moderate extent 31.7 23.2-40.3
  Small extent 28.2 20.2-36.2
  No extent 6.7 2.8-13.0
  No basis to judge/Not applicable 20.0 13.1-28.6
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 5.4 2.1-11.2
  Great extent 22.8 15.6-31.4
  Moderate extent 25.9 18.4-34.6
  Small extent 23.9 16.5-32.6
  No extent 4.3 1.5-9.8
  No basis to judge/Not applicable 16.6 10.4-24.5
  No answer 1.1 0.1-5.0

14g. FDA's top leadership demonstrates a strong commitment to achieving results.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 23.4 19.1-27.8
  Great extent 37.3 32.1-42.5
  Moderate extent 23.0 18.4-27.6
  Small extent 8.8 6.0-12.5
  No extent 1.0 0.3-2.4
  No basis to judge/Not applicable 6.0 3.7-9.2
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 22.1 15.3-30.3
  Great extent 38.2 29.6-46.7
  Moderate extent 21.3 14.3-29.8
  Small extent 13.4 7.8-20.9
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 5.0 1.9-10.5
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 18.4 11.7-26.8
  Great extent 38.2 29.4-47.0
  Moderate extent 23.4 15.9-32.3
  Small extent 6.7 2.8-13.0
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 10.0 5.1-17.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 29.9 21.7-38.1
  Great extent 31.0 22.7-39.3
  Moderate extent 23.9 16.5-32.6
  Small extent 7.6 3.5-14.0
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 1.1 0.1-5.0

14h. FDA's top leadership demonstrates a strong commitment to using performance information to guide decision making.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 10.8 7.7-14.6
  Great extent 29.9 25.0-34.7
  Moderate extent 26.5 21.8-31.2
  Small extent 13.3 9.8-17.5
  No extent 3.2 1.7-5.3
  No basis to judge/Not applicable 15.5 11.7-19.9
  No answer 1.0 0.1-3.2
2--CDER/CBER/CDRH Managers Very great extent 8.9 4.6-15.3
  Great extent 27.8 20.3-35.4
  Moderate extent 27.5 19.9-35.2
  Small extent 18.5 12.0-26.7
  No extent 2.0 0.3-6.3
  No basis to judge/Not applicable 15.2 9.3-22.9
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 19.4 12.6-27.9
  Moderate extent 34.4 25.7-43.2
  Small extent 12.7 7.3-20.2
  No extent 6.7 2.8-13.0
  No basis to judge/Not applicable 21.7 14.5-30.5
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 14.4 8.7-22.0
  Great extent 35.7 27.1-44.2
  Moderate extent 21.7 14.7-30.2
  Small extent 8.7 4.3-15.3
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 13.0 7.5-20.5
  No answer 1.1 0.1-5.0

14i. FDA is investing in resources to improve its capacity to use performance information.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.5 4.2-9.5
  Great extent 20.8 16.4-25.2
  Moderate extent 29.7 24.9-34.5
  Small extent 15.1 11.3-19.6
  No extent 3.8 2.0-6.4
  No basis to judge/Not applicable 23.5 18.9-28.1
  No answer 0.7 0.1-2.2
2--CDER/CBER/CDRH Managers Very great extent 5.0 1.9-10.2
  Great extent 20.3 13.6-28.5
  Moderate extent 28.3 20.3-36.4
  Small extent 15.9 9.8-23.8
  No extent 2.0 0.3-6.3
  No basis to judge/Not applicable 28.5 20.4-36.6
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 12.7 7.3-20.2
  Moderate extent 34.4 25.7-43.2
  Small extent 12.7 7.3-20.2
  No extent 6.7 2.8-13.0
  No basis to judge/Not applicable 30.1 21.6-38.5
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 9.8 5.1-16.6
  Great extent 22.0 15.0-30.5
  Moderate extent 34.6 26.1-43.1
  Small extent 9.8 5.1-16.6
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 16.3 10.1-24.2
  No answer 2.2 0.4-6.7

14j. FDA managers/supervisors at my level take steps to align program performance measures with agencywide goals and objectives.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 14.4 10.7-18.8
  Great extent 39.8 34.8-44.8
  Moderate extent 27.9 23.1-32.8
  Small extent 9.2 6.3-12.7
  No extent 1.9 0.6-4.6
  No basis to judge/Not applicable 6.5 4.0-9.7
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 14.5 8.8-22.0
  Great extent 40.4 31.7-49.1
  Moderate extent 25.9 18.4-34.6
  Small extent 9.4 4.7-16.2
  No extent 1.0 0.1-4.8
  No basis to judge/Not applicable 8.8 4.6-15.1
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 40.5 31.5-49.5
  Moderate extent 37.8 28.9-46.7
  Small extent 10.0 5.1-17.1
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 16.3 10.1-24.2
  Great extent 44.6 35.7-53.6
  Moderate extent 21.7 14.7-30.2
  Small extent 11.9 6.7-19.2
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 1.1 0.1-5.0

14k. FDA managers/supervisors at my level effectively communicate performance information on a routine basis.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 10.7 7.6-14.6
  Great extent 35.1 30.1-40.1
  Moderate extent 34.6 29.4-39.7
  Small extent 14.8 11.2-19.1
  No extent 1.6 0.4-4.3
  No basis to judge/Not applicable 2.6 1.2-4.7
  No answer 0.6 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 6.0 2.6-11.7
  Great extent 31.8 23.6-40.0
  Moderate extent 35.0 26.4-43.6
  Small extent 21.0 14.0-29.5
  No extent 1.0 0.1-4.8
  No basis to judge/Not applicable 4.9 1.9-10.2
  No answer 0.3 0.1-0.9
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 26.1 18.3-35.2
  Moderate extent 47.8 38.6-57.0
  Small extent 19.4 12.6-27.9
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 17.7 11.3-25.7
  Great extent 48.1 39.1-57.0
  Moderate extent 25.6 18.1-34.4
  Small extent 6.5 2.8-12.6
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 1.1 0.1-5.0
  No answer 1.1 0.1-5.0

14l. FDA managers/supervisors at my level take steps to ensure that performance information is useful and/or appropriate.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.2 8.0-15.2
  Great extent 35.4 30.3-40.4
  Moderate extent 33.0 27.9-38.1
  Small extent 12.1 8.8-16.1
  No extent 3.0 1.3-5.8
  No basis to judge/Not applicable 4.8 2.8-7.6
  No answer 0.5 0.1-1.7
2--CDER/CBER/CDRH Managers Very great extent 7.7 3.6-14.2
  Great extent 33.5 25.1-41.9
  Moderate extent 34.4 25.9-43.0
  Small extent 15.3 9.3-23.0
  No extent 1.0 0.1-4.8
  No basis to judge/Not applicable 8.1 3.9-14.4
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 1.7 0.2-6.1
  Great extent 31.1 22.6-39.6
  Moderate extent 38.4 29.5-47.4
  Small extent 18.8 12.3-26.9
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 16.6 10.4-24.5
  Great extent 44.0 35.1-52.9
  Moderate extent 26.4 18.7-35.2
  Small extent 7.6 3.5-14.0
  No extent 4.3 1.5-9.8
  No basis to judge/Not applicable 0.0 0.0-3.1
  No answer 1.1 0.1-5.0

14m. FDA managers/supervisors at my level use performance information to share effective program approaches with others.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 7.8 5.2-11.2
  Great extent 29.4 24.6-34.2
  Moderate extent 36.1 30.9-41.3
  Small extent 16.0 12.3-19.8
  No extent 3.2 1.5-5.9
  No basis to judge/Not applicable 7.1 4.5-10.6
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 6.2 2.6-12.4
  Great extent 23.5 16.4-31.8
  Moderate extent 37.1 28.6-45.7
  Small extent 21.1 14.1-29.6
  No extent 2.9 0.8-7.6
  No basis to judge/Not applicable 9.1 4.6-15.6
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 1.7 0.2-6.1
  Great extent 24.4 16.9-33.4
  Moderate extent 38.4 29.5-47.4
  Small extent 25.5 17.9-34.4
  No extent 5.0 1.8-10.9
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 13.3 7.8-20.7
  Great extent 36.1 27.5-44.8
  Moderate extent 32.9 24.4-41.3
  Small extent 11.2 6.2-18.2
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 1.1 0.1-5.0

Agency Climate (Continued)

The items listed in question 15 below focus on the program(s)/
operation(s)/project(s) that you are responsible for.

(View question)

15. To what extent, if at all, do you agree with the following statements?

(View question)

15a. The individual I report to periodically reviews with me the results or outcomes of the program(s)/operation(s)/project(s) that I am responsible for.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 20.3 16.0-24.6
  Great extent 32.8 27.8-37.9
  Moderate extent 24.7 20.2-29.3
  Small extent 12.0 8.7-16.1
  No extent 7.6 5.0-11.1
  No basis to judge/Not applicable 2.0 0.7-4.5
  No answer 0.5 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 19.8 13.0-28.0
  Great extent 34.9 26.4-43.4
  Moderate extent 21.0 14.1-29.4
  Small extent 15.3 9.3-23.0
  No extent 7.2 3.3-13.3
  No basis to judge/Not applicable 1.9 0.3-6.1
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 15.0 9.0-23.0
  Great extent 31.7 23.2-40.3
  Moderate extent 29.4 21.1-37.8
  Small extent 12.1 7.0-19.1
  No extent 11.7 6.4-19.1
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 23.1 15.9-31.7
  Great extent 25.6 18.1-34.4
  Moderate extent 32.9 24.4-41.3
  Small extent 9.8 5.1-16.6
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 1.1 0.1-5.0

15b. Funding decisions for the program(s)/
operation(s)/project(s) I am responsible for are based on results or outcome-oriented performance information.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.7 4.4-9.9
  Great extent 18.4 14.2-22.6
  Moderate extent 26.1 21.5-30.6
  Small extent 22.2 17.8-26.6
  No extent 12.5 9.1-16.6
  No basis to judge/Not applicable 13.7 10.2-17.9
  No answer 0.5 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 9.1 4.6-15.6
  Great extent 14.7 9.1-22.0
  Moderate extent 26.2 18.7-34.9
  Small extent 25.3 17.8-34.2
  No extent 13.9 8.4-21.2
  No basis to judge/Not applicable 10.8 6.1-17.4
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 16.7 10.3-24.9
  Moderate extent 30.5 22.1-38.9
  Small extent 22.8 15.4-31.6
  No extent 11.7 6.4-19.1
  No basis to judge/Not applicable 11.7 6.4-19.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 4.6 1.7-10.0
  Great extent 17.7 11.3-25.7
  Moderate extent 24.2 16.8-32.9
  Small extent 22.0 15.0-30.5
  No extent 13.0 7.5-20.5
  No basis to judge/Not applicable 17.4 11.0-25.4
  No answer 1.1 0.1-5.0

15c. Staffing and personnel decisions for the program(s)/operation(s)/project(s) I am responsible for are based on results or outcome-oriented performance information.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.4 4.1-9.4
  Great extent 21.8 17.3-26.2
  Moderate extent 29.9 25.2-34.7
  Small extent 22.8 18.4-27.2
  No extent 10.2 7.1-14.1
  No basis to judge/Not applicable 8.5 5.6-12.2
  No answer 0.5 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 7.0 3.2-13.1
  Great extent 19.9 13.3-27.9
  Moderate extent 38.8 30.4-47.3
  Small extent 17.5 11.2-25.4
  No extent 9.8 5.1-16.7
  No basis to judge/Not applicable 7.0 3.2-12.8
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 8.3 4.0-15.1
  Great extent 20.0 13.1-28.6
  Moderate extent 22.1 15.0-30.7
  Small extent 29.4 21.1-37.8
  No extent 13.4 7.7-21.1
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 5.4 2.1-11.2
  Great extent 22.0 15.0-30.5
  Moderate extent 27.7 19.7-35.8
  Small extent 28.5 20.4-36.6
  No extent 8.7 4.3-15.3
  No basis to judge/Not applicable 6.5 2.8-12.6
  No answer 1.1 0.1-5.0

15d. Changes by management above my level to the program(s)/operation(s)/project(s) I am responsible for are based on results or outcome-oriented performance information.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 2.9 1.4-5.3
  Great extent 21.8 17.3-26.3
  Moderate extent 29.1 24.4-33.9
  Small extent 21.2 16.8-25.5
  No extent 9.0 6.1-12.7
  No basis to judge/Not applicable 15.5 11.7-19.9
  No answer 0.5 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 2.9 0.8-7.4
  Great extent 23.9 16.5-32.6
  Moderate extent 35.6 27.1-44.1
  Small extent 16.0 9.9-23.9
  No extent 9.6 5.0-16.4
  No basis to judge/Not applicable 12.0 6.9-19.1
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 11.7 6.4-19.1
  Moderate extent 24.4 16.9-33.4
  Small extent 31.1 22.6-39.6
  No extent 12.7 7.3-20.2
  No basis to judge/Not applicable 15.0 9.0-23.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 1.1 0.1-5.0
  Great extent 22.0 15.0-30.5
  Moderate extent 25.3 17.8-34.1
  Small extent 25.6 18.1-34.4
  No extent 6.5 2.8-12.6
  No basis to judge/Not applicable 18.5 11.9-26.6
  No answer 1.1 0.1-5.0

15e. It is easy to motivate employees to be more results-oriented in the program(s)/
operation(s)/project(s) I am responsible for.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.5 3.4-8.4
  Great extent 24.8 20.1-29.5
  Moderate extent 36.3 31.3-41.4
  Small extent 22.8 18.4-27.3
  No extent 6.2 3.8-9.5
  No basis to judge/Not applicable 3.8 2.0-6.6
  No answer 0.5 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 7.0 3.2-13.1
  Great extent 21.3 14.5-29.4
  Moderate extent 39.8 31.1-48.5
  Small extent 21.8 14.8-30.2
  No extent 6.2 2.6-12.1
  No basis to judge/Not applicable 3.9 1.3-9.0
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 17.7 11.3-26.0
  Moderate extent 36.7 27.9-45.6
  Small extent 29.4 21.1-37.8
  No extent 4.4 1.6-9.4
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 3.3 0.9-8.3
  Great extent 24.8 17.4-33.5
  Moderate extent 38.0 29.3-46.7
  Small extent 23.9 16.5-32.6
  No extent 6.8 3.1-12.8
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 1.1 0.1-5.0

15f. I have sufficient information on the validity of the performance data I use to make decisions.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.4 3.3-8.3
  Great extent 28.8 24.1-33.5
  Moderate extent 32.3 27.2-37.4
  Small extent 19.4 15.3-23.6
  No extent 6.2 3.8-9.5
  No basis to judge/Not applicable 7.4 4.8-10.8
  No answer 0.5 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 5.2 2.0-10.8
  Great extent 24.1 17.2-32.2
  Moderate extent 34.1 25.7-42.5
  Small extent 22.3 15.2-30.7
  No extent 6.1 2.6-12.1
  No basis to judge/Not applicable 8.1 4.0-14.5
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 29.4 21.1-37.8
  Moderate extent 23.4 15.9-32.3
  Small extent 23.4 15.9-32.3
  No extent 5.4 2.5-10.1
  No basis to judge/Not applicable 13.4 7.7-21.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 5.7 2.4-11.4
  Great extent 34.0 25.5-42.5
  Moderate extent 30.7 22.4-39.0
  Small extent 16.6 10.4-24.5
  No extent 6.5 2.8-12.6
  No basis to judge/Not applicable 5.4 2.1-11.2
  No answer 1.1 0.1-5.0

Agency Climate (Continued)

16. To what extent, if at all, do you believe that the following persons or entities pay attention to FDA's use of performance information in management decision making?

(View question)

16a. Secretary of Health and Human Services

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.8 8.5-15.8
  Great extent 13.5 10.0-17.6
  Moderate extent 19.4 15.1-23.7
  Small extent 13.7 10.3-17.7
  No extent 5.3 3.1-8.5
  No basis to judge/Not applicable 35.7 30.6-40.8
  No answer 0.6 0.1-1.6
2--CDER/CBER/CDRH Managers Very great extent 7.0 3.2-13.1
  Great extent 10.0 5.3-17.0
  Moderate extent 23.0 15.7-31.6
  Small extent 11.7 6.6-19.0
  No extent 3.2 1.0-7.8
  No basis to judge/Not applicable 44.7 35.9-53.5
  No answer 0.3 0.1-0.9
3--CFSAN Managers Very great extent 10.0 5.1-17.1
  Great extent 8.3 4.0-15.1
  Moderate extent 23.4 15.9-32.3
  Small extent 21.1 14.0-29.7
  No extent 5.0 1.8-10.9
  No basis to judge/Not applicable 32.2 23.6-40.7
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 16.3 10.1-24.2
  Great extent 19.5 12.8-27.8
  Moderate extent 13.3 7.8-20.7
  Small extent 16.3 10.1-24.2
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 28.1 20.0-36.1
  No answer 1.1 0.1-5.0

16b. FDA Commissioner

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 17.0 13.0-21.0
  Great extent 23.4 18.9-27.9
  Moderate extent 17.0 13.0-21.6
  Small extent 7.8 5.3-11.1
  No extent 3.8 1.9-6.9
  No basis to judge/Not applicable 30.3 25.4-35.1
  No answer 0.7 0.1-2.2
2--CDER/CBER/CDRH Managers Very great extent 11.2 6.2-18.2
  Great extent 22.9 15.8-31.4
  Moderate extent 18.8 12.2-27.0
  Small extent 4.4 1.5-9.6
  No extent 2.9 0.8-7.6
  No basis to judge/Not applicable 39.8 31.1-48.6
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 15.0 9.0-23.0
  Great extent 19.4 12.6-27.9
  Moderate extent 15.0 9.0-23.0
  Small extent 19.4 12.6-27.9
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 29.4 21.1-37.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 22.8 15.6-31.4
  Great extent 27.4 19.4-35.5
  Moderate extent 15.2 9.3-23.0
  Small extent 6.5 2.8-12.6
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 23.7 16.5-32.3
  No answer 2.2 0.4-6.7

16c. Director of your Center or Office

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 26.2 21.6-30.9
  Great extent 28.0 23.2-32.8
  Moderate extent 19.7 15.5-23.9
  Small extent 6.4 4.1-9.5
  No extent 4.8 2.6-7.9
  No basis to judge/Not applicable 13.5 10.0-17.6
  No answer 1.4 0.5-3.2
2--CDER/CBER/CDRH Managers Very great extent 23.1 15.9-31.7
  Great extent 26.8 19.0-34.6
  Moderate extent 25.7 18.1-34.5
  Small extent 5.6 2.1-11.6
  No extent 1.9 0.3-6.1
  No basis to judge/Not applicable 16.0 10.1-23.5
  No answer 0.9 0.1-4.4
3--CFSAN Managers Very great extent 16.7 10.3-24.9
  Great extent 30.1 21.6-38.5
  Moderate extent 24.4 16.9-33.4
  Small extent 13.4 7.7-21.1
  No extent 4.4 1.6-9.4
  No basis to judge/Not applicable 11.1 6.0-18.2
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 32.1 23.7-40.5
  Great extent 26.4 18.7-35.2
  Moderate extent 15.2 9.3-23.0
  Small extent 6.5 2.8-12.6
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 13.3 7.8-20.7
  No answer 3.3 0.9-8.3

16d. The individual I report to

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 26.7 22.2-31.2
  Great extent 31.9 26.9-36.9
  Moderate extent 22.6 18.3-27.0
  Small extent 9.7 6.7-13.5
  No extent 4.2 2.2-7.3
  No basis to judge/Not applicable 3.8 2.0-6.4
  No answer 1.0 0.3-2.7
2--CDER/CBER/CDRH Managers Very great extent 19.6 13.0-27.8
  Great extent 35.9 27.3-44.4
  Moderate extent 24.2 17.0-32.6
  Small extent 11.1 6.2-17.9
  No extent 5.3 2.0-11.2
  No basis to judge/Not applicable 3.9 1.3-9.0
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 20.0 13.1-28.6
  Great extent 26.7 18.8-35.9
  Moderate extent 36.1 27.3-45.0
  Small extent 9.4 4.8-16.1
  No extent 2.7 0.8-6.7
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 38.6 29.9-47.3
  Great extent 26.4 18.7-35.2
  Moderate extent 18.8 12.2-26.9
  Small extent 7.6 3.5-14.0
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 3.3 0.9-8.3

16e. Managers and supervisors at my level

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 16.4 12.6-20.2
  Great extent 37.6 32.5-42.7
  Moderate extent 26.3 21.6-31.0
  Small extent 10.9 7.8-14.8
  No extent 2.8 1.1-5.7
  No basis to judge/Not applicable 3.7 2.1-6.0
  No answer 2.3 0.8-5.0
2--CDER/CBER/CDRH Managers Very great extent 10.7 5.7-17.7
  Great extent 39.2 30.5-47.9
  Moderate extent 30.1 21.9-38.3
  Small extent 10.1 5.4-16.8
  No extent 3.1 0.8-8.2
  No basis to judge/Not applicable 5.8 2.5-11.3
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 10.0 5.1-17.1
  Great extent 28.4 20.1-36.7
  Moderate extent 38.4 29.5-47.4
  Small extent 16.5 10.6-23.9
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 28.8 20.7-37.0
  Great extent 38.3 29.6-47.0
  Moderate extent 16.6 10.4-24.5
  Small extent 10.9 5.9-17.9
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 2.2 0.4-6.7

16f. Employees that report to me

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.2 8.0-15.1
  Great extent 30.1 25.3-35.0
  Moderate extent 29.5 24.7-34.4
  Small extent 14.8 11.2-19.0
  No extent 6.9 4.4-10.3
  No basis to judge/Not applicable 6.7 4.2-10.1
  No answer 0.7 0.1-2.2
2--CDER/CBER/CDRH Managers Very great extent 11.4 6.2-18.6
  Great extent 33.4 25.0-41.8
  Moderate extent 23.9 16.7-32.5
  Small extent 15.9 9.8-23.8
  No extent 7.6 3.5-13.9
  No basis to judge/Not applicable 7.9 3.9-13.9
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 21.1 14.0-29.7
  Moderate extent 38.4 29.5-47.4
  Small extent 19.4 12.6-27.9
  No extent 6.1 2.6-11.8
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 12.2 7.0-19.5
  Great extent 33.6 25.1-42.2
  Moderate extent 24.8 17.4-33.5
  Small extent 17.4 11.0-25.4
  No extent 6.5 2.8-12.6
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 2.2 0.4-6.7

16g. Office of Management and Budget (OMB)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.0 6.3-12.5
  Great extent 12.6 9.3-16.7
  Moderate extent 14.5 10.9-18.8
  Small extent 9.8 6.7-13.6
  No extent 4.5 2.6-7.1
  No basis to judge/Not applicable 48.3 43.1-53.6
  No answer 1.1 0.3-3.0
2--CDER/CBER/CDRH Managers Very great extent 4.4 1.6-9.3
  Great extent 8.3 4.2-14.2
  Moderate extent 10.7 5.9-17.5
  Small extent 9.3 4.7-16.1
  No extent 6.9 3.0-13.1
  No basis to judge/Not applicable 59.3 50.6-68.0
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 16.7 10.3-24.9
  Great extent 9.4 4.8-16.1
  Moderate extent 11.7 6.4-19.1
  Small extent 9.4 4.8-16.1
  No extent 8.3 4.0-15.1
  No basis to judge/Not applicable 44.5 35.3-53.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 10.9 5.9-17.9
  Great extent 14.1 8.4-21.7
  Moderate extent 16.6 10.4-24.5
  Small extent 7.6 3.5-14.0
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 45.4 36.5-54.4
  No answer 2.2 0.4-6.7

16h. Congressional committees

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.0 8.1-14.6
  Great extent 14.7 11.1-18.9
  Moderate extent 12.2 8.9-16.2
  Small extent 14.0 10.4-18.3
  No extent 9.1 6.2-12.7
  No basis to judge/Not applicable 38.7 33.6-43.7
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 5.6 2.3-11.2
  Great extent 8.4 4.3-14.6
  Moderate extent 10.3 5.4-17.2
  Small extent 14.8 9.1-22.3
  No extent 13.5 8.0-20.9
  No basis to judge/Not applicable 47.3 38.7-55.9
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 13.4 7.7-21.1
  Great extent 11.7 6.4-19.1
  Moderate extent 11.1 6.0-18.2
  Small extent 17.7 11.3-26.0
  No extent 6.7 2.8-13.0
  No basis to judge/Not applicable 39.5 30.5-48.5
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 19.5 12.8-27.8
  Great extent 20.9 14.0-29.3
  Moderate extent 14.1 8.4-21.7
  Small extent 8.7 4.3-15.3
  No extent 6.5 2.8-12.6
  No basis to judge/Not applicable 29.1 21.0-37.3
  No answer 1.1 0.1-5.0

16i. The audit community (e.g., GAO, Inspectors General)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 12.6 9.3-16.4
  Great extent 12.9 9.7-16.7
  Moderate extent 14.7 11.0-19.0
  Small extent 11.0 7.8-15.0
  No extent 4.7 2.7-7.6
  No basis to judge/Not applicable 42.7 37.6-47.8
  No answer 1.4 0.4-3.4
2--CDER/CBER/CDRH Managers Very great extent 7.7 3.7-13.9
  Great extent 7.3 3.6-13.0
  Moderate extent 11.5 6.4-18.6
  Small extent 13.4 7.9-20.8
  No extent 5.6 2.1-11.6
  No basis to judge/Not applicable 54.2 45.8-62.7
  No answer 0.3 0.1-0.9
3--CFSAN Managers Very great extent 16.7 10.3-24.9
  Great extent 13.4 7.7-21.1
  Moderate extent 17.7 11.3-26.0
  Small extent 12.7 7.3-20.2
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 36.1 27.3-45.0
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 18.5 11.9-26.6
  Great extent 19.1 12.5-27.2
  Moderate extent 16.3 10.1-24.2
  Small extent 4.3 1.5-9.8
  No extent 7.6 3.5-14.0
  No basis to judge/Not applicable 33.2 24.7-41.6
  No answer 1.1 0.1-5.0

16j. The general public

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.4 4.0-9.7
  Great extent 9.5 6.6-13.1
  Moderate extent 13.9 10.3-18.1
  Small extent 21.8 17.4-26.2
  No extent 14.6 11.0-18.9
  No basis to judge/Not applicable 32.8 27.8-37.9
  No answer 1.0 0.3-2.3
2--CDER/CBER/CDRH Managers Very great extent 6.1 2.6-12.1
  Great extent 8.6 4.2-15.1
  Moderate extent 10.4 5.8-17.1
  Small extent 24.1 16.8-32.9
  No extent 13.5 8.0-20.9
  No basis to judge/Not applicable 37.2 28.8-45.7
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 1.7 0.2-6.1
  Great extent 8.3 4.0-15.1
  Moderate extent 15.0 9.0-23.0
  Small extent 31.7 23.2-40.3
  No extent 17.1 10.9-25.0
  No basis to judge/Not applicable 24.4 16.9-33.4
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 8.7 4.3-15.3
  Great extent 10.1 5.4-16.9
  Moderate extent 14.1 8.4-21.7
  Small extent 19.5 12.8-27.8
  No extent 14.1 8.4-21.7
  No basis to judge/Not applicable 31.3 23.0-39.6
  No answer 2.2 0.4-6.7

Training

17. During the past 3 years, has FDA provided, arranged, or paid for training that would help you to accomplish the following tasks?

(View question)

17a. Conduct strategic planning

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Yes 41.2 36.0-46.4
  No 46.8 41.5-52.1
  Not sure 11.4 8.2-15.3
  Not checked 0.7 0.1-2.2
2--CDER/CBER/CDRH Managers Yes 49.7 40.7-58.6
  No 37.1 28.5-45.7
  Not sure 13.3 7.7-20.7
  Not checked 0.0 0.0-2.9
3--CFSAN Managers Yes 39.5 30.5-48.5
  No 52.2 43.0-61.4
  Not sure 8.3 4.0-15.1
  Not checked 0.0 0.0-4.8
4--ORA Managers Yes 28.5 20.4-36.6
  No 57.4 48.5-66.3
  Not sure 11.9 6.7-19.2
  Not checked 2.2 0.4-6.7

17b. Set program performance goals

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Yes 45.8 40.7-51.0
  No 41.3 36.3-46.2
  Not sure 11.7 8.6-15.3
  Not checked 1.2 0.3-3.2
2--CDER/CBER/CDRH Managers Yes 56.3 47.5-65.0
  No 27.3 19.5-35.1
  Not sure 15.4 9.4-23.3
  Not checked 1.0 0.1-4.8
3--CFSAN Managers Yes 52.8 43.6-62.0
  No 33.8 25.2-42.5
  Not sure 13.4 7.7-21.1
  Not checked 0.0 0.0-4.8
4--ORA Managers Yes 28.2 20.1-36.3
  No 58.8 49.9-67.6
  Not sure 11.9 6.7-19.2
  Not checked 1.1 0.1-5.0

17c. Develop program performance measures

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Yes 42.9 37.7-48.1
  No 43.1 38.0-48.2
  Not sure 13.6 10.3-17.6
  Not checked 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Yes 52.3 43.4-61.2
  No 28.1 20.3-36.0
  Not sure 19.6 13.0-27.6
  Not checked 0.0 0.0-2.9
3--CFSAN Managers Yes 53.4 44.3-62.5
  No 34.9 26.3-43.5
  Not sure 11.7 6.4-19.1
  Not checked 0.0 0.0-4.8
4--ORA Managers Yes 28.2 20.1-36.3
  No 60.9 52.2-69.7
  Not sure 9.8 5.1-16.6
  Not checked 1.1 0.1-5.0

17d. Assess the quality of performance data

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Yes 31.8 26.8-36.8
  No 49.3 44.0-54.5
  Not sure 17.1 13.2-21.0
  Not checked 1.9 0.6-4.6
2--CDER/CBER/CDRH Managers Yes 36.1 27.5-44.7
  No 39.1 30.6-47.6
  Not sure 24.8 17.4-33.4
  Not checked 0.0 0.0-2.9
3--CFSAN Managers Yes 33.4 24.7-42.1
  No 53.2 44.1-62.4
  Not sure 13.4 7.7-21.1
  Not checked 0.0 0.0-4.8
4--ORA Managers Yes 28.2 20.1-36.3
  No 57.7 48.8-66.6
  Not sure 11.9 6.7-19.2
  Not checked 2.2 0.4-6.7

17e. Use program performance information to make decisions

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Yes 33.6 28.5-38.8
  No 49.8 44.5-55.1
  Not sure 15.3 11.8-19.4
  Not checked 1.2 0.4-2.8
2--CDER/CBER/CDRH Managers Yes 36.7 28.2-45.3
  No 41.0 32.4-49.6
  Not sure 22.2 15.2-30.7
  Not checked 0.0 0.0-2.9
3--CFSAN Managers Yes 25.0 17.4-34.1
  No 54.9 45.8-64.0
  Not sure 20.0 13.1-28.6
  Not checked 0.0 0.0-4.8
4--ORA Managers Yes 31.5 23.1-39.8
  No 55.5 46.6-64.4
  Not sure 9.8 5.1-16.6
  Not checked 3.3 0.9-8.3

17f. Link the performance of program(s)/
operation(s)/project(s) to the achievement of FDA's strategic goals

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Yes 35.7 30.5-40.9
  No 44.7 39.4-49.9
  Not sure 18.8 14.7-22.9
  Not checked 0.8 0.2-2.2
2--CDER/CBER/CDRH Managers Yes 41.7 33.0-50.4
  No 34.7 26.4-43.0
  Not sure 23.3 16.1-31.8
  Not checked 0.3 0.1-0.9
3--CFSAN Managers Yes 23.4 15.9-32.3
  No 58.3 49.2-67.3
  Not sure 18.4 11.7-26.8
  Not checked 0.0 0.0-4.8
4--ORA Managers Yes 28.5 20.4-36.6
  No 51.9 43.0-60.9
  Not sure 17.4 11.0-25.4
  Not checked 2.2 0.4-6.7

Management Challenges

18. Based on your experience with the program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all, do you believe that FDA is making progress addressing each of the following management challenges?
(Select one answer in each row.)

Cross-Cutting Issues

(View question)

18a. Improving its information technology and information management

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.1 6.2-12.8
  Great extent 29.9 24.9-34.8
  Moderate extent 35.5 30.4-40.6
  Small extent 19.5 15.4-23.7
  No extent 3.7 1.9-6.5
  No basis to judge/Not applicable 1.9 0.8-3.8
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 11.1 6.0-18.1
  Great extent 27.8 19.8-35.9
  Moderate extent 37.3 28.6-46.0
  Small extent 17.8 11.6-25.4
  No extent 4.1 1.3-9.4
  No basis to judge/Not applicable 1.9 0.3-6.1
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 21.1 14.0-29.7
  Moderate extent 39.5 30.5-48.5
  Small extent 31.1 22.6-39.6
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 6.8 3.1-12.8
  Great extent 28.5 20.4-36.6
  Moderate extent 38.3 29.6-47.0
  Small extent 18.5 11.9-26.6
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 3.6 1.1-8.4
  No answer 1.1 0.1-5.0

18b. Improving access to outside data from other federal agencies and non-governmental entities

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 4.2 2.3-7.0
  Great extent 16.3 12.5-20.8
  Moderate extent 34.0 29.0-39.1
  Small extent 21.1 16.8-25.4
  No extent 8.0 5.5-11.2
  No basis to judge/Not applicable 16.0 12.2-20.5
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 5.4 2.2-11.1
  Great extent 16.5 10.3-24.5
  Moderate extent 31.8 23.8-39.8
  Small extent 22.5 15.5-31.0
  No extent 7.1 3.2-13.2
  No basis to judge/Not applicable 16.7 10.8-24.0
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 0.0 0.0-4.8
  Great extent 16.1 9.9-24.1
  Moderate extent 33.4 24.7-42.1
  Small extent 29.4 21.1-37.8
  No extent 11.1 6.0-18.2
  No basis to judge/Not applicable 10.0 5.1-17.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 3.6 1.1-8.4
  Great extent 14.1 8.4-21.7
  Moderate extent 34.0 25.5-42.5
  Small extent 22.0 15.0-30.5
  No extent 9.8 5.1-16.6
  No basis to judge/Not applicable 15.5 9.5-23.3
  No answer 1.1 0.1-5.0

18c. Recruiting, retaining, and developing a workforce with knowledge, skills and abilities necessary to carry out its mission

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 12.0 8.7-16.0
  Great extent 31.3 26.3-36.2
  Moderate extent 32.1 27.1-37.1
  Small extent 16.8 12.9-20.8
  No extent 5.0 2.7-8.2
  No basis to judge/Not applicable 2.2 1.0-4.1
  No answer 0.7 0.1-2.2
2--CDER/CBER/CDRH Managers Very great extent 11.5 6.4-18.7
  Great extent 33.5 25.1-41.9
  Moderate extent 29.7 21.5-37.9
  Small extent 17.3 11.3-24.9
  No extent 5.1 1.9-10.7
  No basis to judge/Not applicable 1.9 0.3-6.1
  No answer 0.9 0.1-4.4
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 21.7 14.5-30.5
  Moderate extent 48.2 39.1-57.4
  Small extent 20.0 13.1-28.6
  No extent 5.0 1.8-10.9
  No basis to judge/Not applicable 1.7 0.2-6.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 17.7 11.3-25.7
  Great extent 26.7 19.0-35.5
  Moderate extent 31.5 23.1-39.8
  Small extent 17.4 11.0-25.4
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 3.6 1.1-8.4
  No answer 1.1 0.1-5.0

18d. Improving coordination and communication within FDA (both within and between Centers and Offices)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.1 3.8-9.2
  Great extent 22.0 17.7-26.4
  Moderate extent 45.0 39.7-50.4
  Small extent 18.8 14.7-23.0
  No extent 4.3 2.2-7.4
  No basis to judge/Not applicable 3.4 1.8-5.8
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 8.6 4.2-15.3
  Great extent 23.2 16.0-31.7
  Moderate extent 44.7 35.9-53.6
  Small extent 16.7 10.6-24.5
  No extent 2.9 0.8-7.6
  No basis to judge/Not applicable 3.8 1.3-8.6
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 13.4 7.7-21.1
  Moderate extent 50.5 41.3-59.7
  Small extent 28.4 20.1-36.7
  No extent 2.7 0.8-6.7
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 5.7 2.4-11.4
  Great extent 19.5 12.8-27.8
  Moderate extent 50.5 41.6-59.5
  Small extent 15.5 9.5-23.3
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 1.1 0.1-5.0

18e. Improving coordination and communication with other federal agencies

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.0 2.9-7.9
  Great extent 13.6 10.2-17.6
  Moderate extent 41.6 36.4-46.8
  Small extent 17.3 13.3-21.4
  No extent 4.4 2.6-7.1
  No basis to judge/Not applicable 17.5 13.4-21.5
  No answer 0.5 0.1-1.7
2--CDER/CBER/CDRH Managers Very great extent 6.4 2.7-12.5
  Great extent 6.8 3.1-12.5
  Moderate extent 40.7 32.4-49.1
  Small extent 20.3 13.5-28.5
  No extent 4.9 1.9-10.2
  No basis to judge/Not applicable 21.0 14.6-28.6
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 10.0 5.1-17.1
  Moderate extent 33.8 25.2-42.5
  Small extent 25.0 17.4-34.1
  No extent 12.7 7.3-20.2
  No basis to judge/Not applicable 13.4 7.7-21.1
  No answer 1.7 0.2-6.1
4--ORA Managers Very great extent 5.4 2.1-11.2
  Great extent 20.9 14.0-29.3
  Moderate extent 45.1 36.2-54.1
  Small extent 13.0 7.5-20.5
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 12.2 7.0-19.5
  No answer 1.1 0.1-5.0

18f. Improving coordination and communication with experts outside FDA (e.g., academia)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.0 2.9-7.9
  Great extent 22.8 18.2-27.3
  Moderate extent 34.3 29.2-39.5
  Small extent 17.1 13.2-21.0
  No extent 3.1 1.7-5.2
  No basis to judge/Not applicable 17.1 13.1-21.1
  No answer 0.7 0.1-2.3
2--CDER/CBER/CDRH Managers Very great extent 9.0 4.6-15.7
  Great extent 26.9 19.0-34.8
  Moderate extent 36.3 27.7-45.0
  Small extent 13.9 8.5-21.1
  No extent 1.9 0.3-6.1
  No basis to judge/Not applicable 10.8 6.1-17.4
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 1.7 0.2-6.1
  Great extent 13.4 7.7-21.1
  Moderate extent 40.5 31.5-49.5
  Small extent 26.7 18.8-35.9
  No extent 6.1 2.6-11.8
  No basis to judge/Not applicable 11.7 6.4-19.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 2.2 0.4-6.7
  Great extent 17.7 11.3-25.7
  Moderate extent 28.5 20.4-36.6
  Small extent 19.8 13.1-28.1
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 25.3 17.8-34.1
  No answer 1.1 0.1-5.0

18g. Improving the communication of product safety information to the public

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 13.6 10.0-17.9
  Great extent 39.8 34.6-45.1
  Moderate extent 30.1 25.2-35.0
  Small extent 4.0 2.4-6.1
  No extent 1.6 0.7-3.2
  No basis to judge/Not applicable 10.1 7.0-14.0
  No answer 0.7 0.1-2.2
2--CDER/CBER/CDRH Managers Very great extent 17.0 10.8-24.8
  Great extent 38.5 29.8-47.3
  Moderate extent 34.7 26.1-43.3
  Small extent 1.9 0.3-6.1
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 7.9 3.9-14.0
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 36.7 27.9-45.6
  Moderate extent 35.5 26.8-44.2
  Small extent 13.4 7.7-21.1
  No extent 6.1 2.6-11.8
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 13.3 7.8-20.7
  Great extent 37.2 28.5-45.9
  Moderate extent 26.7 19.0-35.5
  Small extent 5.4 2.1-11.2
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 11.9 6.7-19.2
  No answer 2.2 0.4-6.7

18h. Keeping pace with scientific advances necessary to regulate a diverse and expanding product base

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 4.9 2.7-8.2
  Great extent 31.5 26.6-36.4
  Moderate extent 33.0 28.0-38.1
  Small extent 12.4 9.2-16.1
  No extent 1.7 0.6-3.7
  No basis to judge/Not applicable 15.7 12.0-20.1
  No answer 0.7 0.1-2.3
2--CDER/CBER/CDRH Managers Very great extent 5.3 2.0-11.2
  Great extent 37.7 29.1-46.3
  Moderate extent 32.2 23.8-40.6
  Small extent 10.4 5.6-17.3
  No extent 2.2 0.3-7.0
  No basis to judge/Not applicable 11.1 6.3-17.9
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 5.0 1.8-10.9
  Great extent 25.0 17.4-34.1
  Moderate extent 41.1 32.1-50.2
  Small extent 18.8 12.3-26.9
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 8.3 4.0-15.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 2.2 0.4-6.7
  Great extent 25.6 18.1-34.4
  Moderate extent 30.7 22.4-39.0
  Small extent 18.5 11.9-26.6
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 19.8 13.1-28.1
  No answer 1.1 0.1-5.0

18i. Addressing increased need for inspecting domestic establishments for all the product lines that FDA regulates

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.1 4.0-8.9
  Great extent 24.3 19.8-28.9
  Moderate extent 30.5 25.6-35.4
  Small extent 15.7 12.1-19.9
  No extent 2.9 1.4-5.3
  No basis to judge/Not applicable 20.1 15.7-24.5
  No answer 0.3 0.0-1.6
2--CDER/CBER/CDRH Managers Very great extent 3.0 0.8-7.7
  Great extent 21.2 14.3-29.6
  Moderate extent 25.2 17.7-33.9
  Small extent 20.5 13.6-28.9
  No extent 4.4 1.4-10.1
  No basis to judge/Not applicable 25.8 18.3-34.4
  No answer 0.0 0.0-2.9
3--CFSAN Managers Very great extent 3.3 0.9-8.6
  Great extent 15.0 9.0-23.0
  Moderate extent 37.8 28.9-46.7
  Small extent 27.1 19.1-35.2
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 15.0 9.0-23.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 14.4 8.7-22.0
  Great extent 33.2 24.7-41.6
  Moderate extent 26.0 18.4-34.9
  Small extent 10.9 5.9-17.9
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 11.2 6.2-18.2
  No answer 1.1 0.1-5.0



Overseeing Medical Product Safety

(View question)

18j. Addressing increased need for inspecting foreign manufacturers

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 11.1 7.9-15.0
  Great extent 23.7 19.3-28.2
  Moderate extent 23.6 19.0-28.2
  Small extent 7.8 5.3-11.1
  No extent 1.9 0.7-4.1
  No basis to judge/Not applicable 30.8 26.2-35.4
  No answer 1.1 0.3-2.5
2--CDER/CBER/CDRH Managers Very great extent 8.4 4.1-14.9
  Great extent 23.1 15.9-31.8
  Moderate extent 29.1 21.0-37.2
  Small extent 13.2 7.7-20.7
  No extent 4.1 1.3-9.5
  No basis to judge/Not applicable 21.0 14.5-28.8
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 1.7 0.2-6.1
  Great extent 0.0 0.0-4.8
  Moderate extent 13.4 7.7-21.1
  Small extent 6.7 2.8-13.0
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 75.0 65.9-82.6
  No answer 3.3 0.9-8.6
4--ORA Managers Very great extent 18.8 12.2-26.9
  Great extent 37.5 28.8-46.2
  Moderate extent 17.4 11.0-25.4
  Small extent 4.3 1.5-9.8
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 19.8 13.1-28.1
  No answer 1.1 0.1-5.0

18k. Improving its inspection and monitoring of clinical trials

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.4 4.0-9.5
  Great extent 19.5 15.1-23.8
  Moderate extent 19.3 15.2-23.5
  Small extent 9.6 6.7-13.2
  No extent 1.9 0.7-4.1
  No basis to judge/Not applicable 41.7 37.0-46.5
  No answer 1.6 0.6-3.2
2--CDER/CBER/CDRH Managers Very great extent 7.2 3.3-13.3
  Great extent 22.0 14.9-30.4
  Moderate extent 28.7 20.6-36.8
  Small extent 18.5 12.0-26.7
  No extent 3.2 0.8-8.3
  No basis to judge/Not applicable 19.4 13.1-27.1
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 0.0 0.0-4.8
  Great extent 1.7 0.2-6.1
  Moderate extent 3.3 0.9-8.6
  Small extent 1.7 0.2-6.1
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 88.3 80.9-93.6
  No answer 5.0 1.8-10.9
4--ORA Managers Very great extent 9.8 5.1-16.6
  Great extent 20.2 13.4-28.4
  Moderate extent 17.7 11.3-25.7
  Small extent 5.4 2.1-11.2
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 42.6 33.8-51.5
  No answer 2.2 0.4-6.7

18l. Improving its monitoring of post-market study commitments for medical products

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 6.3 3.9-9.5
  Great extent 20.1 15.7-24.6
  Moderate extent 23.2 18.8-27.6
  Small extent 8.1 5.3-11.8
  No extent 2.5 1.1-4.8
  No basis to judge/Not applicable 38.6 33.9-43.3
  No answer 1.2 0.5-2.7
2--CDER/CBER/CDRH Managers Very great extent 12.3 7.0-19.5
  Great extent 26.6 18.9-35.5
  Moderate extent 31.5 23.3-39.7
  Small extent 11.6 6.4-18.9
  No extent 3.4 0.9-8.8
  No basis to judge/Not applicable 13.7 8.1-21.2
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 0.0 0.0-4.8
  Great extent 1.7 0.2-6.1
  Moderate extent 6.7 2.8-13.0
  Small extent 1.7 0.2-6.1
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 83.3 75.1-89.7
  No answer 5.0 1.8-10.9
4--ORA Managers Very great extent 3.3 0.9-8.3
  Great extent 17.7 11.3-25.7
  Moderate extent 24.2 16.8-32.9
  Small extent 5.4 2.1-11.2
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 45.1 36.2-54.1
  No answer 1.1 0.1-5.0

18m. Improving its monitoring and evaluation of adverse events

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 7.2 4.6-10.6
  Great extent 25.5 20.8-30.2
  Moderate extent 24.7 20.1-29.4
  Small extent 5.8 3.6-8.8
  No extent 1.5 0.5-3.5
  No basis to judge/Not applicable 33.8 29.2-38.4
  No answer 1.5 0.5-3.2
2--CDER/CBER/CDRH Managers Very great extent 13.6 8.1-20.9
  Great extent 32.6 24.2-41.1
  Moderate extent 29.9 21.8-38.0
  Small extent 9.6 4.9-16.4
  No extent 1.2 0.1-5.7
  No basis to judge/Not applicable 11.1 6.1-18.2
  No answer 2.0 0.3-6.3
3--CFSAN Managers Very great extent 0.0 0.0-4.8
  Great extent 8.3 4.0-15.1
  Moderate extent 10.0 5.1-17.1
  Small extent 3.3 0.9-8.6
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 75.0 65.9-82.6
  No answer 3.3 0.9-8.6
4--ORA Managers Very great extent 4.3 1.5-9.8
  Great extent 23.1 15.9-31.7
  Moderate extent 25.3 17.8-34.1
  Small extent 4.3 1.5-9.8
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 38.6 29.9-47.3
  No answer 1.1 0.1-5.0

18n. Improving its review of promotional/
advertising materials for drugs

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 4.6 2.7-7.3
  Great extent 16.6 12.7-21.1
  Moderate extent 18.3 14.3-22.2
  Small extent 5.2 3.0-8.2
  No extent 1.6 0.6-3.4
  No basis to judge/Not applicable 52.5 47.5-57.5
  No answer 1.2 0.5-2.7
2--CDER/CBER/CDRH Managers Very great extent 9.2 4.8-15.6
  Great extent 21.1 14.2-29.4
  Moderate extent 23.4 16.9-30.9
  Small extent 7.5 3.4-14.0
  No extent 1.0 0.1-4.8
  No basis to judge/Not applicable 36.9 28.7-45.0
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 0.0 0.0-4.8
  Great extent 1.7 0.2-6.1
  Moderate extent 5.0 1.8-10.9
  Small extent 1.7 0.2-6.1
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 85.0 77.0-91.0
  No answer 5.0 1.8-10.9
4--ORA Managers Very great extent 3.3 0.9-8.3
  Great extent 15.5 9.5-23.3
  Moderate extent 16.6 10.4-24.5
  Small extent 5.4 2.1-11.2
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 54.9 46.0-63.8
  No answer 1.1 0.1-5.0



Overseeing Food Safety

(View question)

18o. Performing its regulatory role under its current statutory authority

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 8.1 5.6-11.3
  Great extent 21.1 17.0-25.3
  Moderate extent 20.0 16.1-24.0
  Small extent 6.5 4.2-9.5
  No extent 1.6 0.7-3.0
  No basis to judge/Not applicable 42.0 37.6-46.4
  No answer 0.7 0.1-2.3
2--CDER/CBER/CDRH Managers Very great extent 2.0 0.3-6.3
  Great extent 6.4 2.7-12.6
  Moderate extent 7.6 3.6-13.7
  Small extent 4.4 1.4-10.1
  No extent 1.0 0.1-4.8
  No basis to judge/Not applicable 77.6 69.0-84.7
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 11.7 6.4-19.1
  Great extent 31.7 23.2-40.3
  Moderate extent 30.5 22.1-38.9
  Small extent 12.7 7.3-20.2
  No extent 8.3 4.0-15.1
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 15.5 9.5-23.3
  Great extent 33.2 24.7-41.6
  Moderate extent 27.1 19.1-35.1
  Small extent 8.7 4.3-15.3
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 13.3 7.8-20.7
  No answer 1.1 0.1-5.0

18p. Improving its monitoring of the safety of a globally sourced food supply

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 5.6 3.6-8.2
  Great extent 19.3 15.3-23.3
  Moderate extent 17.7 14.1-21.4
  Small extent 10.1 7.2-13.6
  No extent 2.2 1.0-4.1
  No basis to judge/Not applicable 44.4 40.0-48.8
  No answer 0.7 0.1-2.3
2--CDER/CBER/CDRH Managers Very great extent 2.2 0.3-7.0
  Great extent 3.1 0.8-8.2
  Moderate extent 5.4 2.3-10.7
  Small extent 5.1 1.9-10.8
  No extent 2.2 0.3-7.0
  No basis to judge/Not applicable 80.9 72.8-87.6
  No answer 1.0 0.1-4.8
3--CFSAN Managers Very great extent 8.3 4.0-15.1
  Great extent 31.7 23.2-40.3
  Moderate extent 24.4 16.9-33.4
  Small extent 22.1 15.0-30.7
  No extent 6.7 2.8-13.0
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 12.2 7.0-19.5
  Great extent 31.0 22.7-39.3
  Moderate extent 26.0 18.4-34.9
  Small extent 14.1 8.4-21.7
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 13.3 7.8-20.7
  No answer 1.1 0.1-5.0

Management Challenges - An Example

19. Please provide an example of how FDA has made progress or not made progress to address any of the management challenges listed in question 18 above. (In your answer, please indicate which challenge from question 18 your example applies to.)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Potential Improvements

20. To what extent, if at all, would each of the following improve your ability to contribute to FDA's goals and responsibilities?

(View question)

20a. Additional staff with needed knowledge, skills, and abilities

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 41.1 35.8-46.4
  Great extent 38.8 33.6-44.1
  Moderate extent 11.5 8.3-15.5
  Small extent 5.1 2.9-8.2
  No extent 1.5 0.4-3.7
  No basis to judge/Not applicable 1.2 0.4-2.8
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 44.1 35.2-53.0
  Great extent 33.4 24.9-41.9
  Moderate extent 12.6 7.2-20.0
  Small extent 7.7 3.6-14.1
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 0.9 0.1-4.4
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 43.2 34.2-52.2
  Great extent 43.4 34.3-52.5
  Moderate extent 8.3 4.0-15.1
  Small extent 3.3 0.9-8.6
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 36.7 28.1-45.4
  Great extent 42.6 33.8-51.5
  Moderate extent 13.0 7.5-20.5
  Small extent 2.2 0.4-6.7
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 1.1 0.1-5.0

20b. Additional staff developmental opportunities

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 24.8 20.2-29.5
  Great extent 42.0 36.7-47.3
  Moderate extent 24.2 19.6-28.8
  Small extent 5.6 3.4-8.7
  No extent 0.6 0.2-1.7
  No basis to judge/Not applicable 2.0 0.8-4.0
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 23.4 16.1-32.1
  Great extent 38.1 29.6-46.7
  Moderate extent 28.8 20.9-36.8
  Small extent 5.2 2.0-10.8
  No extent 0.3 0.1-0.9
  No basis to judge/Not applicable 2.9 0.8-7.6
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 29.4 21.1-37.8
  Great extent 32.8 24.1-41.4
  Moderate extent 21.1 14.0-29.7
  Small extent 15.0 9.0-23.0
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 28.1 20.0-36.1
  Great extent 43.7 34.8-52.6
  Moderate extent 22.8 15.6-31.4
  Small extent 1.1 0.1-5.0
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 2.2 0.4-6.7
  No answer 1.1 0.1-5.0

20c. Improved coordination and communication within FDA (both within and between Centers and Offices)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 35.0 29.9-40.2
  Great extent 35.2 30.1-40.3
  Moderate extent 22.1 17.6-26.5
  Small extent 4.2 2.1-7.2
  No extent 0.8 0.1-2.6
  No basis to judge/Not applicable 1.9 0.8-3.9
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 27.8 19.8-35.7
  Great extent 35.4 26.9-43.9
  Moderate extent 27.3 19.4-35.1
  Small extent 5.2 2.0-11.1
  No extent 1.2 0.1-5.7
  No basis to judge/Not applicable 1.9 0.3-6.1
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 34.4 25.7-43.2
  Great extent 43.8 34.7-53.0
  Moderate extent 21.7 14.5-30.5
  Small extent 0.0 0.0-4.8
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 42.9 34.1-51.8
  Great extent 34.0 25.5-42.5
  Moderate extent 14.4 8.7-22.0
  Small extent 3.3 0.9-8.3
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 3.3 0.9-8.3
  No answer 1.1 0.1-5.0

20d. Improved coordination and communication with other federal governmental entities

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 21.8 17.3-26.2
  Great extent 27.0 22.3-31.8
  Moderate extent 29.7 24.8-34.6
  Small extent 13.3 9.7-17.7
  No extent 2.4 0.9-5.0
  No basis to judge/Not applicable 4.9 3.0-7.6
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 20.0 13.2-28.3
  Great extent 21.2 14.2-29.7
  Moderate extent 30.1 22.3-37.9
  Small extent 17.3 11.0-25.4
  No extent 3.4 0.9-8.8
  No basis to judge/Not applicable 6.9 3.2-12.7
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 22.8 15.4-31.6
  Great extent 42.8 33.7-51.9
  Moderate extent 27.8 19.5-36.0
  Small extent 1.7 0.2-6.1
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 23.9 16.5-32.6
  Great extent 29.1 21.0-37.3
  Moderate extent 27.1 19.1-35.1
  Small extent 11.9 6.7-19.2
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 5.7 2.4-11.4
  No answer 1.1 0.1-5.0

20e. Improved coordination and communication with state governmental entities

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 13.4 10.0-17.5
  Great extent 24.8 20.3-29.2
  Moderate extent 23.3 18.8-27.9
  Small extent 17.6 13.3-21.8
  No extent 10.0 6.8-14.1
  No basis to judge/Not applicable 9.7 6.9-13.1
  No answer 1.2 0.3-3.1
2--CDER/CBER/CDRH Managers Very great extent 5.6 2.1-11.6
  Great extent 17.8 11.4-25.9
  Moderate extent 25.6 18.2-34.2
  Small extent 18.1 11.7-26.0
  No extent 13.6 8.0-21.3
  No basis to judge/Not applicable 17.2 11.0-25.0
  No answer 2.2 0.3-7.0
3--CFSAN Managers Very great extent 21.7 14.5-30.5
  Great extent 32.8 24.1-41.4
  Moderate extent 17.1 10.9-25.0
  Small extent 13.4 7.7-21.1
  No extent 8.3 4.0-15.1
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 19.8 13.1-28.1
  Great extent 31.8 23.4-40.2
  Moderate extent 25.3 17.8-34.1
  Small extent 11.9 6.7-19.2
  No extent 3.3 0.9-8.3
  No basis to judge/Not applicable 6.8 3.1-12.8
  No answer 1.1 0.1-5.0

20f. Improved coordination and communication with foreign regulatory bodies

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 16.2 12.4-20.6
  Great extent 28.1 23.7-32.6
  Moderate extent 22.5 17.9-27.0
  Small extent 16.4 12.5-20.9
  No extent 6.4 3.9-9.9
  No basis to judge/Not applicable 9.6 6.5-13.4
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 12.4 7.1-19.7
  Great extent 34.8 26.6-43.0
  Moderate extent 21.6 14.6-30.0
  Small extent 20.5 13.7-28.8
  No extent 3.4 1.0-8.4
  No basis to judge/Not applicable 6.1 2.6-12.1
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 21.7 14.5-30.5
  Great extent 39.5 30.5-48.5
  Moderate extent 22.1 15.0-30.7
  Small extent 8.3 4.0-15.1
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 18.8 12.2-26.9
  Great extent 22.3 15.2-30.8
  Moderate extent 24.2 16.8-32.9
  Small extent 15.2 9.3-23.0
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 13.0 7.5-20.5
  No answer 1.1 0.1-5.0

20g. Improved coordination and communication with experts outside FDA (e.g., academia)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 16.8 12.8-20.9
  Great extent 34.3 29.2-39.4
  Moderate extent 22.2 17.7-26.6
  Small extent 12.8 9.4-17.0
  No extent 4.8 2.6-8.0
  No basis to judge/Not applicable 8.3 5.6-11.9
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 20.4 13.6-28.8
  Great extent 33.7 25.3-42.1
  Moderate extent 23.7 16.5-32.2
  Small extent 13.6 8.1-21.0
  No extent 2.4 0.5-6.9
  No basis to judge/Not applicable 4.9 1.9-10.3
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 21.1 14.0-29.7
  Great extent 39.5 30.5-48.5
  Moderate extent 22.8 15.4-31.6
  Small extent 10.0 5.1-17.1
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 13.0 7.5-20.5
  Great extent 35.3 26.8-43.9
  Moderate extent 20.6 13.7-29.0
  Small extent 11.9 6.7-19.2
  No extent 5.4 2.1-11.2
  No basis to judge/Not applicable 12.6 7.3-19.7
  No answer 1.1 0.1-5.0

20h. Updated technologies or other tools for data sharing or information management

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 42.0 36.7-47.3
  Great extent 36.5 31.3-41.7
  Moderate extent 13.7 10.2-17.8
  Small extent 3.7 1.9-6.4
  No extent 1.1 0.3-2.9
  No basis to judge/Not applicable 1.9 0.8-3.8
  No answer 1.2 0.3-3.1
2--CDER/CBER/CDRH Managers Very great extent 43.7 34.8-52.6
  Great extent 31.7 23.5-39.9
  Moderate extent 14.1 8.6-21.3
  Small extent 6.5 2.7-12.8
  No extent 0.9 0.1-4.4
  No basis to judge/Not applicable 0.9 0.1-4.4
  No answer 2.2 0.3-7.0
3--CFSAN Managers Very great extent 41.1 32.1-50.2
  Great extent 37.2 28.3-46.0
  Moderate extent 18.4 11.7-26.8
  Small extent 3.3 0.9-8.6
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 0.0 0.0-4.8
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 46.2 37.3-55.2
  Great extent 35.3 26.8-43.9
  Moderate extent 10.9 5.9-17.9
  Small extent 1.1 0.1-5.0
  No extent 1.1 0.1-5.0
  No basis to judge/Not applicable 4.3 1.5-9.8
  No answer 1.1 0.1-5.0

20i. Updated scientific technologies or other tools for the regulation of a diverse and expanding product base

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 35.0 30.0-40.1
  Great extent 31.5 26.5-36.4
  Moderate extent 16.2 12.4-20.8
  Small extent 2.3 1.1-4.2
  No extent 1.7 0.5-4.1
  No basis to judge/Not applicable 12.1 8.7-16.3
  No answer 1.2 0.3-3.1
2--CDER/CBER/CDRH Managers Very great extent 37.4 28.7-46.0
  Great extent 29.0 20.9-37.1
  Moderate extent 21.3 14.3-29.8
  Small extent 2.0 0.3-6.3
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 8.1 4.0-14.5
  No answer 2.2 0.3-7.0
3--CFSAN Managers Very great extent 34.4 25.7-43.2
  Great extent 38.8 29.9-47.8
  Moderate extent 18.4 11.7-26.8
  Small extent 3.3 0.9-8.6
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 5.0 1.8-10.9
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 40.2 31.4-49.0
  Great extent 33.8 25.4-42.2
  Moderate extent 8.7 4.3-15.3
  Small extent 3.3 0.9-8.3
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 10.9 5.9-17.9
  No answer 1.1 0.1-5.0

20j. Updated FDA guidance for industry

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 22.1 17.7-26.5
  Great extent 32.0 27.1-36.9
  Moderate extent 23.9 19.6-28.2
  Small extent 7.0 4.6-10.0
  No extent 1.3 0.3-3.5
  No basis to judge/Not applicable 12.9 9.6-17.0
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 28.4 20.5-36.3
  Great extent 30.7 22.6-38.7
  Moderate extent 26.5 19.2-33.8
  Small extent 9.1 4.7-15.7
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 4.1 1.3-9.5
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 20.0 13.1-28.6
  Great extent 39.5 30.5-48.5
  Moderate extent 28.8 20.6-37.1
  Small extent 6.7 2.8-13.0
  No extent 1.7 0.2-6.1
  No basis to judge/Not applicable 3.3 0.9-8.6
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 15.2 9.3-23.0
  Great extent 36.4 27.8-45.1
  Moderate extent 24.2 16.8-32.9
  Small extent 8.7 4.3-15.3
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 14.4 8.7-22.0
  No answer 1.1 0.1-5.0

20k. Updated product safety regulations

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 22.5 18.1-26.9
  Great extent 25.7 21.1-30.3
  Moderate extent 24.0 19.6-28.4
  Small extent 6.2 3.9-9.3
  No extent 2.2 0.9-4.4
  No basis to judge/Not applicable 17.8 13.6-22.0
  No answer 1.7 0.6-3.7
2--CDER/CBER/CDRH Managers Very great extent 18.6 12.2-26.6
  Great extent 24.3 17.0-32.9
  Moderate extent 30.2 22.0-38.4
  Small extent 11.0 6.1-17.8
  No extent 0.0 0.0-2.9
  No basis to judge/Not applicable 13.7 8.1-21.2
  No answer 2.2 0.3-7.0
3--CFSAN Managers Very great extent 30.5 22.1-38.9
  Great extent 25.0 17.4-34.1
  Moderate extent 27.8 19.5-36.0
  Small extent 6.7 2.8-13.0
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 6.7 2.8-13.0
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 26.0 18.4-34.9
  Great extent 31.0 22.7-39.3
  Moderate extent 23.4 16.2-32.0
  Small extent 2.2 0.4-6.7
  No extent 2.2 0.4-6.7
  No basis to judge/Not applicable 13.0 7.5-20.5
  No answer 2.2 0.4-6.7

20l. Authority for increased access to private firm records during food related emergencies

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 26.8 22.7-31.0
  Great extent 15.8 12.3-19.3
  Moderate extent 8.1 5.5-11.4
  Small extent 2.2 1.0-4.2
  No extent 3.3 1.5-6.1
  No basis to judge/Not applicable 43.1 38.5-47.7
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 7.6 3.6-14.0
  Great extent 6.5 2.9-12.4
  Moderate extent 5.2 2.0-10.9
  Small extent 3.0 0.8-7.7
  No extent 3.1 0.8-8.2
  No basis to judge/Not applicable 73.3 65.4-81.2
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 36.1 27.3-45.0
  Great extent 31.1 22.6-39.6
  Moderate extent 12.7 7.3-20.2
  Small extent 3.3 0.9-8.6
  No extent 3.3 0.9-8.6
  No basis to judge/Not applicable 13.4 7.7-21.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 50.1 41.1-59.0
  Great extent 26.0 18.4-34.9
  Moderate extent 9.8 5.1-16.6
  Small extent 2.2 0.4-6.7
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 10.9 5.9-17.9
  No answer 1.1 0.1-5.0

20m. Authority to accredit third party food inspectors

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 9.4 6.7-12.7
  Great extent 11.3 8.2-15.1
  Moderate extent 11.1 8.4-14.3
  Small extent 8.9 6.1-12.4
  No extent 7.7 5.1-11.1
  No basis to judge/Not applicable 50.8 46.1-55.6
  No answer 0.8 0.1-2.6
2--CDER/CBER/CDRH Managers Very great extent 4.9 1.7-10.5
  Great extent 5.1 1.9-10.8
  Moderate extent 3.2 1.0-7.8
  Small extent 3.0 0.8-7.7
  No extent 3.1 0.8-8.2
  No basis to judge/Not applicable 79.4 71.1-86.3
  No answer 1.2 0.1-5.7
3--CFSAN Managers Very great extent 21.1 14.0-29.7
  Great extent 13.4 7.7-21.1
  Moderate extent 17.1 10.9-25.0
  Small extent 10.0 5.1-17.1
  No extent 13.4 7.7-21.1
  No basis to judge/Not applicable 25.0 17.4-34.1
  No answer 0.0 0.0-4.8
4--ORA Managers Very great extent 9.8 5.1-16.6
  Great extent 16.9 10.7-24.8
  Moderate extent 22.8 15.6-31.4
  Small extent 15.5 9.5-23.3
  No extent 10.9 5.9-17.9
  No basis to judge/Not applicable 23.1 15.9-31.7
  No answer 1.1 0.1-5.0

20n. Other - Please specify below.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

  Question
Choices
Estimated
Percentage
95 Percent
Confidence Interval
1--All FDA Managers Very great extent 4.5 2.7-7.0
  Great extent 1.7 0.7-3.4
  Moderate extent 1.1 0.3-2.8
  Small extent 0.0 0.0-1.0
  No extent 1.3 0.3-3.4
  No basis to judge/Not applicable 25.1 20.5-29.8
  No answer 66.3 61.3-71.3
2--CDER/CBER/CDRH Managers Very great extent 2.1 0.3-6.8
  Great extent 0.9 0.1-4.4
  Moderate extent 0.0 0.0-2.9
  Small extent 0.0 0.0-2.9
  No extent 3.4 0.9-8.8
  No basis to judge/Not applicable 29.4 21.3-37.4
  No answer 64.2 55.7-72.7
3--CFSAN Managers Very great extent 6.7 2.8-13.0
  Great extent 1.7 0.2-6.1
  Moderate extent 0.0 0.0-4.8
  Small extent 0.0 0.0-4.8
  No extent 0.0 0.0-4.8
  No basis to judge/Not applicable 17.7 11.3-26.0
  No answer 73.9 64.8-81.7
4--ORA Managers Very great extent 7.9 3.8-14.2
  Great extent 3.3 0.9-8.3
  Moderate extent 2.2 0.4-6.7
  Small extent 0.0 0.0-3.1
  No extent 0.0 0.0-3.1
  No basis to judge/Not applicable 26.0 18.4-34.9
  No answer 60.6 51.8-69.4

If you answered "Other" above, please specify other improvements.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


21. In your opinion, what are the top three issues that FDA's Management should address to achieve its goals and responsibilities?

(View question)

Issue #1:

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Issue #2:

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Issue #3:

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Additional Comments and Submit Your Responses to GAO

22. If you have any comments that would expand on your responses to any questions in this survey, please enter them in the space below.

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


Please continue to the survey completion question below.

(View question)

23. Are you ready to submit your final completed survey to GAO?
(This is equivalent to mailing a completed paper survey to us. It tells us that your answers are official and final.)

(View question)

The SAS System
 
 
Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office

data intentionally not reported


You may view and print your completed survey by clicking on the Summary link in the menu to the left..

(View question)